0001046257--12-31 2021 Q1 false 0.5 0.5 P3Y 0001046257 ingr:IngredionArgentinaS.a.Member ingr:JointVentureGrupoArcorAndIngredionMember 2021-02-12 2021-02-12 0001046257 ingr:AffiliateOfGrupoArcorMember ingr:JointVentureGrupoArcorAndIngredionMember 2021-02-12 2021-02-12 0001046257 ingr:StockRepurchase2018ProgramMember 2018-10-22 0001046257 us-gaap:TreasuryStockMember 2021-03-31 0001046257 us-gaap:RetainedEarningsMember 2021-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2021-03-31 0001046257 us-gaap:CommonStockMember 2021-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001046257 us-gaap:TreasuryStockMember 2020-12-31 0001046257 us-gaap:RetainedEarningsMember 2020-12-31 0001046257 us-gaap:NoncontrollingInterestMember 2020-12-31 0001046257 us-gaap:CommonStockMember 2020-12-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001046257 us-gaap:TreasuryStockMember 2020-03-31 0001046257 us-gaap:RetainedEarningsMember 2020-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2020-03-31 0001046257 us-gaap:CommonStockMember 2020-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001046257 us-gaap:TreasuryStockMember 2019-12-31 0001046257 us-gaap:RetainedEarningsMember 2019-12-31 0001046257 us-gaap:NoncontrollingInterestMember 2019-12-31 0001046257 us-gaap:CommonStockMember 2019-12-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-03-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001046257 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001046257 2020-01-01 2020-12-31 0001046257 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001046257 srt:MinimumMember ingr:PerformanceSharesMarketBasedMember 2021-01-01 2021-03-31 0001046257 srt:MinimumMember ingr:PerformanceSharesInternalBasedMember 2021-01-01 2021-03-31 0001046257 srt:MaximumMember ingr:PerformanceSharesMarketBasedMember 2021-01-01 2021-03-31 0001046257 srt:MaximumMember ingr:PerformanceSharesInternalBasedMember 2021-01-01 2021-03-31 0001046257 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001046257 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001046257 ingr:SouthAmericaSegmentMember 2021-01-01 2021-03-31 0001046257 ingr:NorthAmericaSegmentMember 2021-01-01 2021-03-31 0001046257 ingr:EMEASegmentMember 2021-01-01 2021-03-31 0001046257 ingr:AsiaPacificSegmentMember 2021-01-01 2021-03-31 0001046257 ingr:SouthAmericaSegmentMember 2020-01-01 2020-03-31 0001046257 ingr:NorthAmericaSegmentMember 2020-01-01 2020-03-31 0001046257 ingr:EMEASegmentMember 2020-01-01 2020-03-31 0001046257 ingr:AsiaPacificSegmentMember 2020-01-01 2020-03-31 0001046257 us-gaap:EmployeeSeveranceMember 2021-03-31 0001046257 us-gaap:EmployeeSeveranceMember 2020-12-31 0001046257 us-gaap:OtherRestructuringMember ingr:SouthAmericaJointVentureRestructuringMember 2021-01-01 2021-03-31 0001046257 us-gaap:EmployeeSeveranceMember ingr:SouthAmericaJointVentureRestructuringMember 2021-01-01 2021-03-31 0001046257 ingr:ReorganizationOfSupplyChainAndOpeningOfWarehousesMember ingr:CostSmartCostOfSalesProgramNorthAmericaMember 2021-01-01 2021-03-31 0001046257 ingr:OtherRestructuringIncludingProfessionalServicesMember ingr:CostSmartProgramSgProgramMember 2021-01-01 2021-03-31 0001046257 ingr:SouthAmericaJointVentureRestructuringMember 2021-01-01 2021-03-31 0001046257 ingr:CostSmartProgramCostOfSalesProgramMember 2021-01-01 2021-03-31 0001046257 us-gaap:OtherRestructuringMember ingr:CostSmartProgramCostOfSalesProgramProductionFacilityClosureAustraliaMember 2020-01-01 2020-03-31 0001046257 us-gaap:EmployeeSeveranceMember ingr:CostSmartProgramSgProgramMember 2020-01-01 2020-03-31 0001046257 ingr:ProfessionalServicesMember ingr:CostSmartCostOfSalesProgramNorthAmericaMember 2020-01-01 2020-03-31 0001046257 ingr:OtherRestructuringIncludingProfessionalServicesMember ingr:CostSmartProgramSgProgramMember 2020-01-01 2020-03-31 0001046257 ingr:AssetWriteOffMember ingr:CostSmartProgramCostOfSalesProgramProductionFacilityClosureAustraliaMember 2020-01-01 2020-03-31 0001046257 ingr:AcceleratedDepreciationMember ingr:CostSmartProgramCostOfSalesProgramProductionFacilityClosureAustraliaMember 2020-01-01 2020-03-31 0001046257 ingr:AcceleratedDepreciationMember ingr:CostSmartCostOfSalesProgramNorthAmericaMember 2020-01-01 2020-03-31 0001046257 ingr:CostSmartProgramSgProgramMember 2020-01-01 2020-03-31 0001046257 ingr:CostSmartProgramCostOfSalesProgramProductionFacilityClosureAustraliaMember 2020-01-01 2020-03-31 0001046257 ingr:CostSmartProgramCostOfSalesProgramMember 2020-01-01 2020-03-31 0001046257 ingr:CostSmartCostOfSalesProgramNorthAmericaMember 2020-01-01 2020-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember ingr:NetSalesAndCostOfSalesMember 2021-01-01 2021-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2021-01-01 2021-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember ingr:NetSalesAndCostOfSalesMember 2020-01-01 2020-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001046257 ingr:KatechMember us-gaap:SubsequentEventMember 2021-04-01 2021-04-01 0001046257 ingr:VerdientFoodsIncMember 2020-11-03 2020-11-03 0001046257 us-gaap:EmployeeSeveranceMember 2021-01-01 2021-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-03-31 0001046257 us-gaap:CashFlowHedgingMember 2021-01-01 2021-03-31 0001046257 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-03-31 0001046257 us-gaap:CashFlowHedgingMember 2020-01-01 2020-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0001046257 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0001046257 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001046257 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001046257 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001046257 ingr:PurecircleLimitedMember 2020-07-01 0001046257 ingr:FormerPurecircleShareholdersMember ingr:PurecircleLimitedMember 2020-07-01 0001046257 ingr:OtherLongTermBorrowingsMember 2021-03-31 0001046257 ingr:OtherLongTermBorrowingsMember 2020-12-31 0001046257 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-03-31 0001046257 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-03-31 0001046257 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001046257 us-gaap:PerformanceSharesMember 2021-03-31 0001046257 us-gaap:EmployeeStockOptionMember 2021-03-31 0001046257 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001046257 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001046257 ingr:DisposalGroupIncludingDiscontinuedOperationLiabilitiesNoncurrentMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:SouthAmericanSubsidiariesPropertyPlantAndEquipmentMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2020-12-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2020-12-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2020-12-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2020-12-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-03-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:NondesignatedMember 2021-03-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:NondesignatedMember 2020-12-31 0001046257 ingr:NonCurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001046257 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:NondesignatedMember 2021-03-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:NondesignatedMember 2021-03-31 0001046257 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001046257 us-gaap:DesignatedAsHedgingInstrumentMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2020-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001046257 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:NondesignatedMember 2020-12-31 0001046257 ingr:AccountsReceivableNetMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 us-gaap:NondesignatedMember 2020-12-31 0001046257 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001046257 us-gaap:DesignatedAsHedgingInstrumentMember 2020-12-31 0001046257 country:US us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001046257 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001046257 country:US us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0001046257 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-03-31 0001046257 country:US us-gaap:PensionPlansDefinedBenefitMember 2021-03-31 0001046257 us-gaap:PensionPlansDefinedBenefitMember 2021-03-31 0001046257 us-gaap:ForeignPlanMember 2021-01-01 2021-03-31 0001046257 us-gaap:PostemploymentRetirementBenefitsMember 2021-01-01 2021-03-31 0001046257 us-gaap:PostemploymentRetirementBenefitsMember 2020-01-01 2020-03-31 0001046257 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-03-31 0001046257 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0001046257 ingr:SeniorNotes6.625PercentDue2037Member 2021-03-31 0001046257 ingr:SeniorNotes3.9PercentDue1june2050Member 2021-03-31 0001046257 ingr:SeniorNotes3.20PercentDueOctober12026Member 2021-03-31 0001046257 ingr:SeniorNotes2.2PercentDue1june2030Member 2021-03-31 0001046257 ingr:SeniorNotes6.625PercentDue2037Member 2020-12-31 0001046257 ingr:SeniorNotes3.9PercentDue1june2050Member 2020-12-31 0001046257 ingr:SeniorNotes3.20PercentDueOctober12026Member 2020-12-31 0001046257 ingr:SeniorNotes2.2PercentDue1june2030Member 2020-12-31 0001046257 ingr:TermLoanCreditAgreementAmendedMember 2021-03-31 0001046257 ingr:TermLoanCreditAgreementMember 2020-12-31 0001046257 ingr:SeniorNotes4625PercentDueNovember12020Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember 2020-12-31 0001046257 ingr:SeniorNotes4625PercentDueNovember12020Member 2020-12-31 0001046257 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember ingr:FinancingCostsMember 2020-01-01 2020-03-31 0001046257 2020-03-31 0001046257 2019-12-31 0001046257 ingr:PurecircleLimitedMember 2020-07-01 0001046257 ingr:PurecircleLimitedMember 2021-01-01 2021-03-31 0001046257 ingr:VerdientFoodsIncMember 2020-11-03 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:StocktonCaliforniaAndLaneCoveAustraliaPropertyPlantAndEquipmentMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:SouthAmericanSubsidiariesPropertyPlantAndEquipmentMember 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2021-03-31 0001046257 ingr:SouthAmericaSegmentMember 2021-03-31 0001046257 ingr:NorthAmericaSegmentMember 2021-03-31 0001046257 ingr:EMEASegmentMember 2021-03-31 0001046257 ingr:AsiaPacificSegmentMember 2021-03-31 0001046257 ingr:SouthAmericaSegmentMember 2020-12-31 0001046257 ingr:NorthAmericaSegmentMember 2020-12-31 0001046257 ingr:EMEASegmentMember 2020-12-31 0001046257 ingr:AsiaPacificSegmentMember 2020-12-31 0001046257 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001046257 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001046257 ingr:PerformanceSharesAndOtherShareBasedAwardsMember 2021-01-01 2021-03-31 0001046257 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001046257 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0001046257 ingr:PerformanceSharesAndOtherShareBasedAwardsMember 2020-01-01 2020-03-31 0001046257 us-gaap:CashFlowHedgingMember 2021-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0001046257 us-gaap:CashFlowHedgingMember 2020-12-31 0001046257 2020-12-31 0001046257 ingr:AmyrisBrazilianManufacturingFacilityMember srt:ScenarioForecastMember us-gaap:SubsequentEventMember 2021-05-03 2021-05-03 0001046257 ingr:VerdientFoodsIncMember 2018-01-01 2018-12-31 0001046257 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001046257 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001046257 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001046257 ingr:AwardDateSegmentTwo2021Member ingr:PerformanceSharesInternalBasedMember 2021-01-01 2021-03-31 0001046257 ingr:AwardDateSegmentOne2021Member ingr:PerformanceSharesMarketBasedMember 2021-01-01 2021-03-31 0001046257 ingr:PerformanceSharesMarketBasedMember 2020-01-01 2020-12-31 0001046257 ingr:PerformanceSharesMarketBasedMember 2019-01-01 2019-12-31 0001046257 us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0001046257 us-gaap:PerformanceSharesMember 2019-01-01 2019-12-31 0001046257 ingr:AwardDate2021Member us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0001046257 ingr:AwardDateSegmentOne2021Member ingr:PerformanceSharesInternalBasedMember 2021-01-01 2021-03-31 0001046257 ingr:PerformanceSharesMarketBasedMember 2021-01-01 2021-03-31 0001046257 ingr:PerformanceSharesInternalBasedMember 2021-01-01 2021-03-31 0001046257 ingr:PerformanceSharesInternalBasedMember 2020-01-01 2020-12-31 0001046257 ingr:PerformanceSharesInternalBasedMember 2019-01-01 2019-12-31 0001046257 ingr:AwardGrantedIn2018Member us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:SouthAmericaSegmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:NorthAmericaSegmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:EMEASegmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:AsiaPacificSegmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:SouthAmericaSegmentMember 2020-01-01 2020-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:NorthAmericaSegmentMember 2020-01-01 2020-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:EMEASegmentMember 2020-01-01 2020-03-31 0001046257 us-gaap:OperatingSegmentsMember ingr:AsiaPacificSegmentMember 2020-01-01 2020-03-31 0001046257 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0001046257 2021-03-31 0001046257 srt:MinimumMember us-gaap:CommodityContractMember 2021-01-01 2021-03-31 0001046257 srt:MaximumMember us-gaap:CommodityContractMember 2021-01-01 2021-03-31 0001046257 ingr:JointVentureGrupoArcorAndIngredionMember 2021-02-12 0001046257 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:SouthAmericanSubsidiariesPropertyPlantAndEquipmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:StocktonCaliforniaAndLaneCoveAustraliaPropertyPlantAndEquipmentMember 2021-01-01 2021-03-31 0001046257 ingr:DisposalGroupIncludingDiscontinuedOperationLiabilitiesNoncurrentMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:SouthAmericanSubsidiariesPropertyPlantAndEquipmentMember 2021-01-01 2021-03-31 0001046257 us-gaap:OtherNoncurrentAssetsMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember ingr:SouthAmericanSubsidiariesPropertyPlantAndEquipmentMember 2021-01-01 2021-03-31 0001046257 2020-01-01 2020-03-31 0001046257 ingr:CornCommodityMember 2021-03-31 0001046257 ingr:NaturalGasCommodityMember 2021-03-31 0001046257 ingr:PurecircleLimitedMember 2020-07-01 2020-07-01 0001046257 ingr:PurecircleLimitedMember 2021-03-31 0001046257 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2021-03-31 0001046257 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2021-03-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2021-03-31 0001046257 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0001046257 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2020-12-31 0001046257 2021-04-30 0001046257 2021-01-01 2021-03-31 iso4217:CAD iso4217:EUR xbrli:shares iso4217:USD utr:MMBTU utr:bu xbrli:pure ingr:facility ingr:item iso4217:USD xbrli:shares ingr:segment

Table of Contents

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

​

(Mark One)

​ | ​
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the quarterly period ended March 31, 2021

or

​

​ | ​
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the transition period from to

​

Commission File Number 1-13397

​

Ingredion Inc orporated

(Exact name of registrant as specified in its charter)

​

Delaware

(State or other jurisdiction of incorporation or organization)

​

22-3514823

(I.R.S. Employer Identification Number)

​

​ | ​ | ​
5 Westbrook Corporate Center Westchester, Illinois | ​ | 60154
(Address of principal executive offices) | ​ | (Zip Code)

​

(708) 551-2600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $.01 par value per share | INGR | New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​ | ​ | ​
​ | ​ | ​
​ | ​ | ​
Large accelerated filer ☒ | ​ | Accelerated filer ☐
​ | ​ | ​
Non-accelerated filer ☐ | ​ | Smaller reporting company ☐
​ | ​ | ​
​ | ​ | Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

​

​ | ​ | ​
Class | ​ | Outstanding at April 30, 2021
Common Stock, $.01 par value | ​ | 66,975,448 shares

​

​

​

Table of Contents

INGREDION INCORPORATED

FORM 10-Q

TABLE OF CONTENTS

​

​ | ​ | Page
Part I | ​ | ​
​ | ​ | ​
Item 1 | Financial Statements | 3
​ | Condensed Consolidated Statements of (Loss) Income | 3
​ | Condensed Consolidated Statements of Comprehensive Loss | 4
​ | Condensed Consolidated Balance Sheets | 5
​ | Condensed Consolidated Statements of Equity and Redeemable Equity | 6
​ | Condensed Consolidated Statements of Cash Flows | 7
​ | Notes to Condensed Consolidated Financial Statements | 8
Item 2 | Management’s discussion and analysis of financial condition and results of operations | 25
Item 3 | Quantitative and qualitative disclosures about market risk | 33
Item 4 | Controls and procedures | 33
​ | ​ | ​
Part II | ​ | ​
​ | ​ | ​
Item 1 | Legal proceedings | 34
Item 2 | Unregistered sales of equity securities and use of proceeds | 34
Item 6 | Exhibits | 35
Signatures | 37

​

​

​

​

2

Table of Contents

​

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of (Loss) Income

(Unaudited)

​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions, except per share amounts) |  | 2021 |  | 2020 | ​
Net sales | ​ | $ | 1,614 | ​ | $ | 1,543 | ​
Cost of sales | ​ | ​ | 1,263 | ​ | ​ | 1,220 | ​
Gross profit | ​ | ​ | 351 | ​ | ​ | 323 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating expenses | ​ | ​ | 153 | ​ | ​ | 154 | ​
Other (income) expense, net | ​ | ​ | (2) | ​ | ​ | 2 | ​
Restructuring/impairment charges | ​ | ​ | 370 | ​ | ​ | 14 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating (loss) income | ​ | ​ | (170) | ​ | ​ | 153 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Financing costs, net | ​ | ​ | 19 | ​ | ​ | 18 | ​
Other, non-operating (income), net | ​ | ​ | (1) | ​ | ​ | (1) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(Loss) income before income taxes | ​ | ​ | (188) | ​ | ​ | 136 | ​
Provision for income taxes | ​ | ​ | 55 | ​ | ​ | 58 | ​
Net (loss) income | ​ | ​ | (243) | ​ | ​ | 78 | ​
Less: Net income attributable to non-controlling interests | ​ | ​ | 3 | ​ | ​ | 3 | ​
Net (loss) income attributable to Ingredion | ​ | $ | (246) | ​ | $ | 75 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average common shares outstanding: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic | ​ | ​ | 67.3 | ​ | ​ | 67.1 | ​
Diluted | ​ | ​ | 67.3 | ​ | ​ | 67.8 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per common share of Ingredion: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic | ​ | $ | (3.66) | ​ | $ | 1.12 | ​
Diluted | ​ | $ | (3.66) | ​ | $ | 1.11 | ​

​

See Notes to Condensed Consolidated Financial Statements

​

​

​

3

Table of Contents

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions) |  | 2021 |  | 2020 |
Net (loss) income |  | $ | (243) | ​ | $ | 78 | ​
Other comprehensive income: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Gains (losses) on cash flow hedges, net of income tax effect of $7 and $12, respectively | ​ | ​ | 22 | ​ | ​ | (34) | ​
(Gains) losses on cash flow hedges reclassified to earnings, net of income tax effect of $ — and $2, respectively | ​ | ​ | (1) | ​ | ​ | 4 | ​
Currency translation adjustment | ​ | ​ | (52) | ​ | ​ | (134) | ​
Comprehensive loss | ​ | ​ | (274) | ​ | ​ | (86) | ​
Less: Comprehensive income attributable to non-controlling interests | ​ | ​ | 5 | ​ | ​ | — | ​
Comprehensive loss attributable to Ingredion | ​ | $ | (279) | ​ | $ | (86) | ​

​

See Notes to Condensed Consolidated Financial Statements

​

​

​

​

4

Table of Contents

​

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Balance Sheets

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | December 31, | ​
(in millions, except share and per share amounts) |  | 2021 |  | 2020 |
​ | ​ | (Unaudited) | ​ | ​ | ​ | ​
Assets |  | ​ | ​ |  | ​ | ​ | ​
Current assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents | ​ | $ | 576 | ​ | $ | 665 | ​
Short-term investments | ​ | ​ | 1 | ​ | ​ | — | ​
Accounts receivable, net | ​ | ​ | 1,025 | ​ | ​ | 1,011 | ​
Inventories | ​ | ​ | 950 | ​ | ​ | 917 | ​
Prepaid expenses | ​ | ​ | 58 | ​ | ​ | 54 | ​
Total current assets | ​ | ​ | 2,610 | ​ | ​ | 2,647 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Property, plant and equipment, net of accumulated depreciation of $3,165 and $3,175, respectively | ​ | ​ | 2,355 | ​ | ​ | 2,455 | ​
Goodwill | ​ | ​ | 899 | ​ | ​ | 902 | ​
Other intangible assets, net of accumulated amortization of $235 and $229, respectively | ​ | ​ | 437 | ​ | ​ | 444 | ​
Operating lease assets | ​ | ​ | 182 | ​ | ​ | 173 | ​
Deferred income tax assets | ​ | ​ | 24 | ​ | ​ | 23 | ​
Other assets | ​ | ​ | 296 | ​ | ​ | 214 | ​
Total assets | ​ | $ | 6,803 | ​ | $ | 6,858 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities and equity | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Short-term borrowings | ​ | $ | 448 | ​ | $ | 438 | ​
Accounts payable and accrued liabilities | ​ | ​ | 932 | ​ | ​ | 1,020 | ​
Total current liabilities | ​ | ​ | 1,380 | ​ | ​ | 1,458 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Non-current liabilities | ​ | ​ | 219 | ​ | ​ | 227 | ​
Long-term debt | ​ | ​ | 1,749 | ​ | ​ | 1,748 | ​
Non-current operating lease liabilities | ​ | ​ | 145 | ​ | ​ | 136 | ​
Deferred income tax liabilities | ​ | ​ | 219 | ​ | ​ | 217 | ​
Liabilities held for sale | ​ | ​ | 337 | ​ | ​ | — | ​
Total liabilities | ​ | ​ | 4,049 | ​ | ​ | 3,786 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Share-based payments subject to redemption | ​ | ​ | 21 | ​ | ​ | 30 | ​
Redeemable non-controlling interests | ​ | ​ | 70 | ​ | ​ | 70 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ingredion stockholders’ equity: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Preferred stock — authorized 25,000,000 shares — $0.01 par value, none issued | ​ | ​ | — | ​ | ​ | — | ​
Common stock — authorized 200,000,000 shares — $0.01 par value, 77,810,875 issued at March 31, 2021 and December 31, 2020, respectively | ​ | ​ | 1 | ​ | ​ | 1 | ​
Additional paid-in capital | ​ | ​ | 1,155 | ​ | ​ | 1,150 | ​
Less: Treasury stock (common stock: 10,737,015 and 10,795,346 shares at March 31, 2021 and December 31, 2020, respectively) at cost | ​ | ​ | (1,022) | ​ | ​ | (1,024) | ​
Accumulated other comprehensive loss | ​ | ​ | (1,164) | ​ | ​ | (1,133) | ​
Retained earnings | ​ | ​ | 3,667 | ​ | ​ | 3,957 | ​
Total Ingredion stockholders’ equity | ​ | ​ | 2,637 | ​ | ​ | 2,951 | ​
Non-redeemable non-controlling interests | ​ | ​ | 26 | ​ | ​ | 21 | ​
Total equity | ​ | ​ | 2,663 | ​ | ​ | 2,972 | ​
Total liabilities and equity | ​ | $ | 6,803 | ​ | $ | 6,858 | ​

​

See Notes to Condensed Consolidated Financial Statements

​

5

Table of Contents

​

​

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Equity and Redeemable Equity

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Total Equity | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Non- | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Redeemable | ​ | Share-based | ​ | Redeemable | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Accumulated Other | ​ | ​ | ​ | ​ | Non- | ​ | Payments | ​ | Non- | ​
​ | ​ | Preferred | ​ | Common | ​ | Paid-In | ​ | Treasury | ​ | Comprehensive | ​ | Retained | ​ | Controlling | ​ | Subject to | ​ | Controlling | ​
(in millions) |  | Stock | ​ | Stock |  | Capital |  | Stock |  | Loss |  | Earnings |  | Interests |  | Redemption |  | Interests |
Balance, December 31, 2020 | ​ | $ | — | ​ | $ | 1 | ​ | $ | 1,150 | ​ | $ | (1,024) | ​ | $ | (1,133) | ​ | $ | 3,957 | ​ | $ | 21 | ​ | $ | 30 | ​ | $ | 70 | ​
Net (loss) attributable to Ingredion | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (246) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) attributable to non-controlling interests | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 4 | ​ | ​ | ​ | ​ | ​ | (1) | ​
Dividends declared | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (44) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Repurchases of common stock, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (14) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Share-based compensation, net of issuance | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 5 | ​ | ​ | 16 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (9) | ​ | ​ | ​ | ​
Other comprehensive (loss) income | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (31) | ​ | ​ | ​ | ​ | ​ | 1 | ​ | ​ | ​ | ​ | ​ | 1 | ​
Balance, March 31, 2021 | ​ | $ | — | ​ | $ | 1 | ​ | $ | 1,155 | ​ | $ | (1,022) | ​ | $ | (1,164) | ​ | $ | 3,667 | ​ | $ | 26 | ​ | $ | 21 | ​ | $ | 70 | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Total Equity | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Non- | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Redeemable | ​ | Share-based | ​ | Redeemable | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Accumulated Other | ​ | ​ | ​ | ​ | Non- | ​ | Payments | ​ | Non- |
​ | ​ | Preferred | ​ | Common | ​ | Paid-In | ​ | Treasury | ​ | Comprehensive | ​ | Retained | ​ | Controlling | ​ | Subject to | ​ | Controlling |
(in millions) |  | Stock | ​ | Stock |  | Capital |  | Stock |  | Loss |  | Earnings |  | Interests |  | Redemption |  | Interests |
Balance, December 31, 2019 |  | $ | — | ​ | $ | 1 | ​ | $ | 1,137 | ​ | $ | (1,040) | ​ | $ | (1,158) | ​ | $ | 3,780 | ​ | $ | 21 | ​ | $ | 31 | ​ | $ | — | ​
Net income attributable to Ingredion | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 75 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income attributable to non-controlling interests | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 3 | ​ | ​ | ​ | ​ | ​ | ​ | ​
Dividends declared | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (42) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Share-based compensation, net of issuance | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 5 | ​ | ​ | 12 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (8) | ​ | ​ | ​ | ​
Other comprehensive income (loss) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (164) | ​ | ​ | ​ | ​ | ​ | (3) | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance, March 31, 2020 | ​ | $ | — | ​ | $ | 1 |  | $ | 1,142 |  | $ | (1,028) |  | $ | (1,322) |  | $ | 3,813 |  | $ | 21 |  | $ | 23 |  | $ | — | ​

​

See Notes to Condensed Consolidated Financial Statements

​

​

6

Table of Contents

​

Ingredion Incorporated (“Ingredion”)

Condensed Consolidated Statements of Cash Flows

(Unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions) |  | 2021 |  | 2020 | ​
Cash provided by operating activities | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net (loss) income | ​ | $ | (243) | ​ | $ | 78 | ​
Non-cash charges to net (loss) income: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | 52 | ​ | ​ | 54 | ​
Mechanical stores expense | ​ | ​ | 14 | ​ | ​ | 13 | ​
Deferred income taxes | ​ | ​ | (4) | ​ | ​ | — | ​
Assets held for sale impairment | ​ | ​ | 360 | ​ | ​ | — | ​
Other | ​ | ​ | 7 | ​ | ​ | 13 | ​
Changes in working capital: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Accounts receivable and prepaid expenses | ​ | ​ | (56) | ​ | ​ | (69) | ​
Inventories | ​ | ​ | (69) | ​ | ​ | (33) | ​
Accounts payable and accrued liabilities | ​ | ​ | (5) | ​ | ​ | 17 | ​
Margin accounts | ​ | ​ | (16) | ​ | ​ | (20) | ​
Other | ​ | ​ | (18) | ​ | ​ | 12 | ​
Cash provided by operating activities | ​ | ​ | 22 | ​ | ​ | 65 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash used for investing activities | ​ | ​ | ​ | ​ | ​ | ​ | ​
Capital expenditures and mechanical stores purchases, net of proceeds on disposals | ​ | ​ | (63) | ​ | ​ | (98) | ​
Short-term investments | ​ | ​ | (1) | ​ | ​ | 2 | ​
Cash used for investing activities | ​ | ​ | (64) | ​ | ​ | (96) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash (used for) provided by financing activities | ​ | ​ | ​ | ​ | ​ | ​ | ​
Proceeds from borrowings | ​ | ​ | 46 | ​ | ​ | 405 | ​
Payments on debt | ​ | ​ | (36) | ​ | ​ | (303) | ​
Repurchases of common stock, net | ​ | ​ | (14) | ​ | ​ | — | ​
Issuances of common stock for share-based compensation, net of settlements | ​ | ​ | 7 | ​ | ​ | 2 | ​
Dividends paid, including to non-controlling interests |  | ​ | (43) |  | ​ | (42) | ​
Cash (used for) provided by financing activities | ​ | ​ | (40) | ​ | ​ | 62 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Effects of foreign exchange rate changes on cash | ​ | ​ | (7) | ​ | ​ | (17) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(Decrease) increase in cash and cash equivalents | ​ | ​ | (89) | ​ | ​ | 14 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents, beginning of period | ​ | ​ | 665 | ​ | ​ | 264 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and cash equivalents, end of period | ​ | $ | 576 | ​ | $ | 278 | ​

​

See Notes to Condensed Consolidated Financial Statements

​

​

7

Table of Contents

INGREDION INCORPORATED (“Ingredion”)

Notes to Condensed Consolidated Financial Statements

​

1. Interim Financial Statements

​

References to the “Company” are to Ingredion Incorporated (“Ingredion”) and its consolidated subsidiaries. These statements should be read in conjunction with the consolidated financial statements and the related notes to those statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

​

The unaudited Condensed Consolidated Financial Statements as of March 31, 2021 and for the three months ended March 31, 2021, and 2020, included herein were prepared by management on the same basis as the Company’s audited Consolidated Financial Statements for the year ended December 31, 2020, and reflect all adjustments (consisting solely of normal recurring items unless otherwise noted) which are, in the opinion of management, necessary for the fair presentation of the Condensed Consolidated Statements of (Loss) Income, Condensed Consolidated Statements of Comprehensive (Loss) Income, Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Equity and Redeemable Equity, and Condensed Consolidated Statements of Cash Flows. The results for the interim period are not necessarily indicative of the results expected for the full year or any other future period.

​

2. Summary of Significant Accounting Standards and Policies

​

For detailed information about the Company’s significant accounting standards and policies, see Note 2 of the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to the Company’s significant accounting standards and policies for the three months ended March 31, 2021.

​

​

3. Acquisitions

​

On July 1, 2020, the Company completed its acquisition of a controlling interest in PureCircle Limited (“PureCircle”). PureCircle is one of the leading producers and innovators of plant-based stevia sweeteners for the global food and beverage industries. To complete the closing, the Company made a total cash payment of $208 million, net of $14 million of cash acquired, which it funded from cash on hand. After the closing, the Company owns 75% of PureCircle, with the remaining 25% owned by former PureCircle shareholders. PureCircle is consolidated by Ingredion for financial reporting purposes, with a corresponding redeemable non-controlling interest of $74 million recorded for the portion not owned by the Company at the time of acquisition. The results of PureCircle are reported on a one-month lag within the Company’s Condensed Consolidated Financial Statements during the integration process of the companies. The results of the acquired operations are included in the Company’s consolidated results from the acquisition date within the Asia-Pacific reportable segment. Pro-forma results of operations for the acquisition have not been presented as the effect of the acquisition would not be material to the Company’s results of operations for any periods presented.

​

The Company has completed its allocation of the purchase price to the assets acquired and liabilities assumed, except for goodwill, contingent liabilities, and taxes, which are preliminarily recorded based on available information and incorporating management’s best estimates. Contingent liabilities and taxes remain preliminary pending receipt of certain information required to finalize the determination of fair value. The assets acquired and liabilities assumed in the transaction are generally recorded at their estimated acquisition date fair values, while transaction costs associated with the acquisition were expensed as incurred.

​

Goodwill represents the amount by which the purchase price exceeds the estimated fair value of the net assets acquired. The goodwill results from synergies and other operational benefits expected to be derived from the acquisition. The goodwill related to PureCircle is not tax-deductible due to the structure of the acquisition.

​

8

Table of Contents

The following table summarizes the preliminary purchase price allocations for the PureCircle acquisition as of March 31, 2021:

​

​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​
(in millions) |  | ​ | PureCircle | ​
Working capital (excluding cash) | ​ | $ | 60 | ​
Property, plant and equipment | ​ |  | 91 | ​
Other, net | ​ | ​ | (22) | ​
Identifiable intangible assets | ​ |  | 68 | ​
Goodwill | ​ |  | 85 | ​
Total fair value, net of cash | ​ | ​ | 282 | ​
Less: Non-redeemable non-controlling interests | ​ | ​ | 74 | ​
Total purchase price, net of cash |  | $ | 208 | ​

​

The identifiable intangible assets for the acquisition of a controlling interest in PureCircle include customer relationships, tradenames, and proprietary technology. The fair values of these intangible assets were determined to be Level 3 under the fair value hierarchy. Level 3 inputs are unobservable inputs for an asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for fair value estimates to be made in situations in which there is little, if any, market activity for an asset or liability at the measurement date. For more information on the fair value hierarchy, see Note 6 of the Notes to the Condensed Consolidated Financial Statements.

​

During the 12 months ended December 31, 2018, the Company entered into an equity method investment with Verdient Foods, Inc. (“Verdient”) by acquiring 20% of its outstanding shares. Verdient is a Canada-based producer of pulse-based protein concentrates and flours from peas, lentils, and fava beans for human food applications. On November 3, 2020, the Company acquired the remaining 80% of the outstanding shares, as well as the leased land and buildings not owned by Verdient. To complete the closing, the Company made a total cash payment of CAD $33 million (USD $26 million), which it funded from cash on hand. The results of the acquired operation are included in the Company’s consolidated results from the acquisition date within the North America business segment. A preliminary allocation of the purchase price to the assets acquired and liabilities assumed was made based on available information and incorporating management’s best estimates. The acquisition of Verdient added $14 million of goodwill and $15 million of tangible assets as of the acquisition date. Pro-forma results of operations for the acquisition have not been presented as the effect of the acquisition would not be material to the Company’s results of operations for any periods presented.

​

The Company incurred $1 million of pre-tax acquisition and integration costs for the three months ended March 31, 2021, associated with the PureCircle acquisition. The Company incurred an insignificant amount of pre-tax acquisition and integration costs for the three months ended March 31, 2020.

​

4. Revenue Recognition

​

The Company applies the provisions of ASC 606-10, Revenue from Contracts with Customers. The Company recognizes revenue under the core principle to depict the transfer of products to customers in an amount reflecting the consideration the Company expects to receive. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

​

The Company identifies customer purchase orders, which in some cases are governed by a master sales agreement, as the contracts with its customers. For each contract, the Company considers the transfer of products, each of which is distinct, to be the identified performance obligation. In determining the transaction price for the performance obligation, the Company evaluates whether the price is subject to adjustment to determine the consideration to which the Company expects to be entitled. The pricing model can be fixed or variable within the contract. The variable pricing model is based on historical commodity pricing and is determinable prior to completion of the performance obligation. Additionally, the Company has certain sales adjustments for volume incentive discounts and other discount arrangements that reduce the transaction price. The reduction of the transaction price is estimated using the expected value method based on an analysis of historical volume incentives or discounts, over a period of time considered adequate to account for current pricing and business trends. Historically, actual volume incentives and discounts relative to those estimated and included when determining the transaction price have not materially differed. Volume incentives and discounts are accrued at the

9

Table of Contents

satisfaction of the performance obligation and accounted for in Accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets. These amounts were not significant as of March 31, 2021 or December 31, 2020. The product price as specified in the contract, net of any discounts, is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Payment is received shortly after the performance obligation is satisfied; therefore, the Company has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component.

​

Revenue is recognized when the Company’s performance obligation is satisfied and control is transferred to the customer, which occurs at a point in time, either upon delivery to an agreed upon location or to the customer. Further, in determining whether control has transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer.

​

Shipping and handling activities related to contracts with customers represent fulfillment costs and are recorded in Cost of sales. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from revenues. The Company applies a practical expedient to expense costs to obtain a contract as incurred as most contracts are one year or less. These costs primarily include the Company’s internal sales force compensation. Under the terms of these programs, such costs are generally earned and the costs are recognized at the time the revenue is recognized.

​

From time to time, the Company may enter into long-term contracts with its customers. Historically, the contracts entered into by the Company do not result in significant contract assets or liabilities. Any such arrangements are accounted for in Other assets or Accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets. There were no significant contract assets or liabilities as of March 31, 2021 or December 31, 2020.

​

The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s operations are classified into four reportable business segments: North America, South America, Asia-Pacific and Europe, Middle East and Africa (“EMEA”). The nature, amount, timing and uncertainty of the Company’s Net sales are managed by the Company primarily based on its geographic segments. Each region’s product sales are unique to each region and have unique risks.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions) |  | 2021 |  | 2020 |
Net sales to unaffiliated customers: | ​ | ​ | ​ | ​ | ​ | ​ | ​
North America | ​ | $ | 945 | ​ | $ | 963 | ​
South America | ​ | ​ | 273 | ​ | ​ | 237 | ​
Asia-Pacific | ​ | ​ | 235 | ​ | ​ | 189 | ​
EMEA | ​ | ​ | 161 | ​ | ​ | 154 | ​
Total net sales | ​ | $ | 1,614 | ​ | $ | 1,543 | ​

​

​

5. Restructuring and Impairment Charges

​

For the three months ended March 31, 2021, the Company recorded $370 million of pre-tax impairment and restructuring charges. These charges included impairment charges of $360 million related to held for sale treatment of net assets expected to be contributed to an unconsolidated joint venture in the third quarter of 2021, as described below, and pre-tax restructuring charges of $10 million primarily related to the Company’s Cost Smart program.

​

For the three months ended March 31, 2020, the Company recorded $14 million of pre-tax restructuring and impairment charges. These charges included $9 million of pre-tax restructuring and impairment charges for the Company’s Cost Smart Cost of sales program, and $5 million of pre-tax restructuring and impairment charges for the Company’s Cost Smart selling, general, and administrative expense (“SG&A”) program.

​

10

Table of Contents

Impairment Charges

​

On February 12, 2021, the Company signed an agreement with an affiliate of Grupo Arcor, an Argentine food company, to establish a joint venture to combine manufacturing operations in Argentina in order to sell value-added ingredients to customers in Argentina, Chile and Uruguay. The joint venture will be 51% owned by Grupo Arcor and 49% owned by Ingredion. The joint venture will operate five manufacturing facilities that produce value-added ingredients including glucose syrups, maltose, fructose, starch, and maltodextrins, among others, that are marketed to the food, beverage, pharmaceutical and other industries. The joint venture will be managed by a jointly-appointed team of executives. Subject to the satisfaction of regulatory approvals and other closing conditions, the joint venture transaction is expected to close in the third quarter of 2021.

​

In connection with its entry into the joint venture agreement, the Company has classified the assets and liabilities to be transferred to the joint venture as held for sale in its Condensed Consolidated Financial Statements during the three months ended March 31, 2021. Accordingly, the Company recorded those assets and liabilities at fair value, less estimated transaction costs, resulting in an impairment charge of $360 million, of which $311 million was related to the required valuation allowance of the cumulative translation losses associated with the contributed net assets and $49 million was related to the write-down of the contributed net assets to the agreed upon fair value. The non-cash impairment charge is subject to finalization based on ending balances and foreign exchange impacts until the transaction closes. The Company recorded the impairment within Restructuring/impairment charges in the Condensed Consolidated Statements of (Loss) Income for the three months ended March 31, 2021. The held for sale assets and liabilities were classified within the Company’s South America reportable business segment.

​

The following table presents the major classes of assets and liabilities classified as held for sale for the joint venture agreement. Assets classified as held for sale are included in Other assets and liabilities held for sale are included in Liabilities held for sale on the Condensed Consolidated Balance Sheets as of March 31, 2021.

​

​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​
(in millions) | ​ | March 31, 2021 | ​
Cash and cash equivalents |  | $ | 2 | ​
Accounts receivable, net | ​ | ​ | 36 | ​
Inventories | ​ | ​ | 26 | ​
Prepaid expenses | ​ | ​ | 1 | ​
Property, plant and equipment, net | ​ | ​ | 57 | ​
Other assets | ​ | ​ | 1 | ​
Impairment provision to record at fair value, less cost to sell | ​ | ​ | (49) | ​
Assets held for sale | ​ | $ | 74 | ​
​ | ​ | ​ | ​ | ​
Accounts payable | ​ | $ | 22 | ​
Accrued liabilities | ​ | ​ | 4 | ​
Impairment provision related to cumulative translation losses | ​ | ​ | 311 | ​
Liabilities held for sale | ​ | $ | 337 | ​
​ | ​ | ​ | ​ | ​

​

During the year ended December 31, 2020, the Company identified property, plant and equipment assets within the Stockton, California and Lane Cove, Australia locations that met the held for sale criteria. The Company expects to sell these assets at a fair value equal to or greater than the carrying value and did not record a gain or loss associated with the reclassification of these assets to held for sale. The value of these assets as of March 31, 2021 is $8 million. The assets are reported within Other assets on the Condensed Consolidated Balance Sheets. A total of $82 million of assets held for sale, including the held for sale assets described above, were reported within Other assets as of March 31, 2021. During April 2021, the Company completed the sale of the property, plant and equipment held for sale at the Stockton, California location and sold the assets for more than the carrying value.

​

11

Table of Contents

Restructuring Charges

​

For the three months ended March 31, 2021, the Company recorded a total of $10 million of pre-tax restructuring charges. The Company recorded pre-tax restructuring charges of $5 million for its Cost Smart SG&A program. These costs consist primarily of other costs, including professional services costs.

​

The Company also recorded $3 million of pre-tax restructuring charges for its Cost Smart Cost of sales program for the three months ended March 31, 2021. These costs were primarily in the Company’s North America segment, of which $2 million related to the reorganization of North America’s supply chain.

​

For the three months ended March 31, 2021, the Company also recorded $2 million of pre-tax restructuring charges, consisting of $1 million of employee severance and $1 million of other costs, related to the planned joint venture transaction.

​

For the three months ended March 31, 2020, the Company recorded a total of $14 million of pre-tax restructuring and impairment charges. The Company recorded $9 million of pre-tax restructuring charges related to its Cost Smart Cost of sales program. The Company recorded $5 million of pre-tax restructuring charges in relation to the closure of the Lane Cove, Australia production facility, consisting of $3 million of asset write-offs, $1 million of accelerated depreciation, and $1 million of other costs. The Company also recorded an additional $4 million of pre-tax restructuring charges, primarily in North America, during the three months ended March 31, 2020. These costs included $3 million of accelerated depreciation and $1 million of professional services.

​

For the three months ended March 31, 2020, the Company also recorded pre-tax restructuring charges of $5 million for its Cost Smart SG&A program. These costs included $3 million of other costs, including professional services, and $2 million of severance. These charges were recorded primarily in the Company’s North America operations.

​

A summary of the Company’s employee-related severance accrual as of March 31, 2021 is as follows (in millions):

​

​ | ​ | ​ | ​ | ​
Balance in severance accrual as of December 31, 2020 |  | $ | 12 | ​
Joint venture related | ​ | ​ | 1 | ​
Payments made to terminated employees | ​ | ​ | (4) | ​
Balance in severance accrual as of March 31, 2021 |  | $ | 9 | ​

​

The entire $9 million severance accrual as of March 31, 2021 is expected to be paid in the next 12 months.

​

​

6. Financial Instruments, Derivatives and Hedging Activities

​

The Company is exposed to market risk stemming from changes in commodity prices (primarily corn and natural gas), foreign currency exchange rates and interest rates. In the normal course of business, the Company actively manages its exposure to these market risks by entering into various hedging transactions, authorized under established policies that place controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment grade counterparties. Derivative financial instruments used by the Company consist of commodity-related futures, options and swap contracts, foreign currency-related forward contracts, interest rate swaps, and treasury locks (“T-Locks”).

​

Commodity price hedging: The Company’s principal use of derivative financial instruments is to manage commodity price risk relating to anticipated purchases of corn and natural gas to be used in the manufacturing process, generally over the next 12 to 24 months. The Company maintains a commodity-price risk management strategy that uses derivative instruments to minimize significant, unanticipated earnings fluctuations caused by commodity-price volatility. To manage price risk related to corn purchases primarily in North America, the Company uses corn futures and option contracts that trade on regulated commodity exchanges to lock-in corn costs associated with fixed-priced customer sales contracts. The Company also uses over-the-counter natural gas swaps in North America to hedge a portion of its natural gas usage. These derivative financial instruments limit the impact that volatility resulting from fluctuations in market prices will have on corn and natural gas purchases. The Company’s natural gas derivatives and the majority of its corn derivatives have been designated as cash flow hedging instruments.

​

12

Table of Contents

The Company enters into certain corn derivative instruments that are not designated as hedging instruments as defined by ASC 815, Derivatives and Hedging. Therefore, the realized and unrealized gains and losses from these instruments are recognized in cost of sales during each accounting period. These derivative instruments also mitigate commodity price risk related to anticipated purchases of corn.

​

For commodity hedges designated as cash flow hedges, unrealized gains and losses associated with marking the commodity hedging contracts to market (fair value) are recorded as a component of other comprehensive loss (“OCL”) and included in the equity section of the Condensed Consolidated Balance Sheets as part of Accumulated other comprehensive loss (“AOCL”). These amounts are subsequently reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings, or in the month a hedge is determined to be ineffective. The Company assesses the effectiveness of a commodity hedge contract based on changes in the contract’s fair value. The changes in the market value of such contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in the price of the hedged items. Gains and losses from cash flow hedging instruments reclassified from AOCL to earnings are reported as Cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.

​

As of March 31, 2021, the Company had outstanding futures and option contracts that hedged the forecasted purchase of approximately 81 million bushels of corn and outstanding swap and option contracts that hedged the forecasted purchase of approximately 33 million mmbtu’s of natural gas.

​

Foreign currency hedging: Due to the Company’s global operations, including operations in many emerging markets, the Company is exposed to fluctuations in foreign currency exchange rates. As a result, the Company has exposure to translational foreign-exchange risk when the results of its foreign operations are translated to U.S. dollars and to transactional foreign-exchange risk when transactions not denominated in the functional currency are revalued. The Company’s foreign-exchange risk management strategy uses derivative financial instruments such as foreign currency forward contracts, swaps and options to manage its transactional foreign exchange risk. The Company enters into foreign currency derivative instruments that are designated as both cash flow hedging instruments as well as instruments not designated as hedging instruments as defined by ASC 815, Derivatives and Hedging, in order to mitigate transactional foreign-exchange risk. Gains and losses from derivative financial instruments not designated as hedging instruments are marked to market in earnings during each accounting period.

​

The Company hedges certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $487 million and $410 million as of March 31, 2021 and December 31, 2020, respectively. The Company also hedges certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $276 million and $224 million as of March 31, 2021 and December 31, 2020, respectively.

​

The Company hedges certain assets using foreign currency cash flow hedging instruments, which had a notional value of $256 million and $401 million as of March 31, 2021 and December 31, 2020, respectively. The Company also hedges certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $422 million and $542 million as of March 31, 2021 and December 31, 2020, respectively.

​

Interest rate hedging: The Company assesses its exposure to variability in interest rates by identifying and monitoring changes in interest rates that may adversely impact future cash flows and the fair value of existing debt instruments, and by evaluating hedging opportunities. The Company’s risk management strategy is to monitor interest rate risk attributable to both the Company’s outstanding and forecasted debt obligations as well as the Company’s offsetting hedge positions. Derivative financial instruments that have been used by the Company to manage its interest rate risk consist of interest rate swaps and T-Locks.

​

The Company periodically enters into interest rate swaps to hedge its exposure to interest rate changes. The changes in fair value of interest rate swaps designated as hedging instruments that effectively offset the variability in the fair value of outstanding debt obligations are reported in earnings. These amounts offset the gains or losses (the changes in fair value) of the hedged debt instruments that are attributable to changes in interest rates (the hedged risk), which are also recognized in earnings. As of March 31, 2021 and December 31, 2020, the Company did not have any outstanding interest rate swaps. During the year ended December 31, 2020, the Company had an outstanding interest rate swap agreement that converted the interest rates on $200 million of its $400 million 4.625% senior notes due November 1, 2020, to variable rates. The Company redeemed these notes in July 2020 and settled the outstanding interest rate swap.

​

13

Table of Contents

The Company periodically enters into T-Locks to hedge its exposure to interest rate changes. The T-Locks are designated as hedges of the variability in cash flows associated with future interest payments caused by market fluctuations in the benchmark interest rate until the fixed interest rate is established, and are accounted for as cash flow hedges. Accordingly, changes in the fair value of the T-Locks are recorded to AOCL until the consummation of the underlying debt offering, at which time any realized gain (loss) is amortized to earnings over the life of the debt. The Company did not have outstanding T-locks as of March 31, 2021 or December 31, 2020. T-locks outstanding as of March 31, 2020 were settled during the three months ended June 30, 2020. The corresponding realized loss was recorded in AOCL and is being amortized to earnings over the life of the senior notes sold.

​

The derivative instruments designated as cash flow hedges included in AOCL as of March 31, 2021 and December 31, 2020 are reflected below:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Derivatives in Cash Flow Hedging Relationships | ​ | ​ | Gains (Losses) included in AOCL | ​
(in millions) | ​ | ​ | March 31, 2021 | ​ | December 31, 2020 | ​
Commodity contracts, net of income tax effect of $24 and $16, respectively | ​ | $ | 67 | ​ | $ | 47 | ​
Foreign currency contracts, net of income tax effect of $1 and $ — , respectively | ​ | ​ | - | ​ | ​ | (1) | ​
Interest rate contracts, net of income tax effect of $1 | ​ | ​ | (4) | ​ | ​ | (4) | ​
Total | ​ | $ | 63 | ​ | $ | 42 | ​

​

The fair value and balance sheet location of the Company’s derivative instruments, presented gross in the Condensed Consolidated Balance Sheets, are reflected below:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value of Hedging Instruments as of March 31, 2021 | ​
​ | ​ | Designated Hedging Instruments (in millions) | ​ | Non-Designated Hedging Instruments (in millions) | ​
Balance Sheet Location | ​ | ​ | Commodity Contracts | ​ | ​ | Foreign Currency Contracts | ​ | Total | ​ | ​ | Commodity Contracts | ​ | ​ | Foreign Currency Contracts | ​ | Total | ​
Accounts receivable, net | ​ | $ | 54 | ​ | $ | 1 | ​ | $ | 55 | ​ | $ | 3 | ​ | $ | 7 | ​ | $ | 10 | ​
Other assets | ​ | ​ | 1 | ​ | ​ | 1 | ​ | ​ | 2 | ​ | ​ | — | ​ | ​ | 1 | ​ | ​ | 1 | ​
Assets | ​ | ​ | 55 | ​ | ​ | 2 | ​ | ​ | 57 | ​ | ​ | 3 | ​ | ​ | 8 | ​ | ​ | 11 | ​
Accounts payable and accrued liabilities | ​ | ​ | 2 | ​ | ​ | 4 | ​ | ​ | 6 | ​ | ​ | 1 | ​ | ​ | 10 | ​ | ​ | 11 | ​
Non-current liabilities | ​ | ​ | 1 | ​ | ​ | — | ​ | ​ | 1 | ​ | ​ | — | ​ | ​ | 1 | ​ | ​ | 1 | ​
Liabilities | ​ | ​ | 3 | ​ | ​ | 4 | ​ | ​ | 7 | ​ | ​ | 1 | ​ | ​ | 11 | ​ | ​ | 12 | ​
Net (Liabilities)/Assets | ​ | $ | 52 | ​ | $ | (2) | ​ | $ | 50 | ​ | $ | 2 | ​ | $ | (3) | ​ | $ | (1) | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value of Hedging Instruments as of December 31, 2020 | ​
​ | ​ | Designated Hedging Instruments (in millions) | ​ | Non-Designated Hedging Instruments (in millions) | ​
Balance Sheet Location | ​ | ​ | Commodity Contracts | ​ | ​ | Foreign Currency Contracts | ​ | Total | ​ | ​ | Commodity Contracts | ​ | ​ | Foreign Currency Contracts | ​ | Total | ​
Accounts receivable, net | ​ | $ | 50 | ​ | $ | 7 | ​ | $ | 57 | ​ | $ | 3 | ​ | $ | 4 | ​ | $ | 7 | ​
Other assets | ​ | ​ | 4 | ​ | ​ | — | ​ | ​ | 4 | ​ | ​ | — | ​ | ​ | 1 | ​ | ​ | 1 | ​
Assets | ​ | ​ | 54 | ​ | ​ | 7 | ​ | ​ | 61 | ​ | ​ | 3 | ​ | ​ | 5 | ​ | ​ | 8 | ​
Accounts payable and accrued liabilities | ​ | ​ | 4 | ​ | ​ | 12 | ​ | ​ | 16 | ​ | ​ | 1 | ​ | ​ | 8 | ​ | ​ | 9 | ​
Non-current liabilities | ​ | ​ | 2 | ​ | ​ | — | ​ | ​ | 2 | ​ | ​ | — | ​ | ​ | 2 | ​ | ​ | 2 | ​
Liabilities | ​ | ​ | 6 | ​ | ​ | 12 | ​ | ​ | 18 | ​ | ​ | 1 | ​ | ​ | 10 | ​ | ​ | 11 | ​
Net (Liabilities)/Assets | ​ | $ | 48 | ​ | $ | (5) | ​ | $ | 43 | ​ | $ | 2 | ​ | $ | (5) | ​ | $ | (3) | ​

​

14

Table of Contents

Additional information relating to the Company’s derivative instruments is presented below:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Derivatives in Cash Flow | ​ | Gains (Losses) Recognized in OCL on Derivatives | ​ | Income | ​ | Gains (Losses) Reclassified from AOCL into Income | ​
Hedging Relationships | ​ | Three Months Ended March 31, | ​ | Statement | ​ | Three Months Ended March 31, | ​
(in millions) |  | 2021 |  | 2020 |  | Location |  | 2021 |  | 2020 | ​
Commodity contracts | ​ | $ | 27 | ​ | $ | (37) | ​ | Cost of sales | ​ | $ | (1) | ​ | $ | 7 | ​
Foreign currency contracts | ​ | ​ | 2 | ​ | ​ | (5) | ​ | Net sales/Cost of sales | ​ | ​ | 2 | ​ | ​ | (1) | ​
Interest rate contracts | ​ | ​ | — | ​ | ​ | (4) | ​ | Financing costs, net | ​ | ​ | — | ​ | ​ | — | ​
Total | ​ | $ | 29 | ​ | $ | (46) | ​ | ​ | ​ | $ | 1 | ​ | $ | 6 | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Derivatives in Fair Value Hedging | Income Statement Location of | ​ | Gains (Losses) Recognized in Income | ​ | Income Statement | ​ | Gains (Losses) Recognized in Income | ​
Relationships | Derivatives Designated as | ​ | Three Months Ended March 31, | ​ | Location | ​ | Three Months Ended March 31, | ​
(in millions) | Hedging Instruments | ​ | 2021 | ​ | 2020 | ​ | of Hedged Items | ​ | 2021 | ​ | 2020 | ​
Interest rate contracts | Financing costs, net | ​ | $ | — | ​ | $ | 3 | ​ | Financing costs, net | ​ | $ | — | ​ | $ | (3) | ​

​

As of March 31, 2021, AOCL included $64 million of net gains (net of income taxes of $23 million) on settled commodities-related derivatives instruments, foreign currency hedges, and T-Locks designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.

​

Fair Value Measurements: Presented below are the fair values of the Company’s financial instruments and derivatives as of the dates presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of March 31, 2021 | ​ | As of December 31, 2020 | ​
(in millions) |  | Total |  | Level 1 (a) |  | Level 2 (b) |  | Level 3 (c) |  | Total |  | Level 1 (a) |  | Level 2 (b) |  | Level 3 (c) |
Available for sale securities | ​ | $ | 12 | ​ | $ | 12 | ​ | $ | — | ​ | $ | — | ​ | $ | 11 | ​ | $ | 11 | ​ | $ | — | ​ | $ | — | ​
Derivative assets | ​ | ​ | 68 | ​ | ​ | 53 | ​ | ​ | 15 | ​ | ​ | — | ​ | ​ | 69 | ​ | ​ | 53 | ​ | ​ | 16 | ​ | ​ | — | ​
Derivative liabilities | ​ | ​ | 19 | ​ | ​ | 2 | ​ | ​ | 17 | ​ | ​ | — | ​ | ​ | 29 | ​ | ​ | 3 | ​ | ​ | 26 | ​ | ​ | — | ​
Long-term debt | ​ | ​ | 1,919 | ​ | ​ | — | ​ | ​ | 1,919 | ​ | ​ | — | ​ | ​ | 1,751 | ​ | ​ | — | ​ | ​ | 1,751 | ​ | ​ | — | ​

​

| (a) | Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities. |

| (b) | Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 2 inputs are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data. |

| (c) | Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. |

​

The carrying values of cash equivalents, short-term investments, accounts receivable, accounts payable and short-term borrowings approximate fair values. Commodity futures, options, and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of the Company’s Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities. As of March 31, 2021, the carrying value and fair value of the Company’s Long-term debt was approximately $1.7 billion and $1.9 billion, respectively.

​

15

Table of Contents

7. Debt

​

Presented below are the Company’s debt carrying amounts, net of related discounts, premiums, and debt issuance costs as of March 31, 2021 and December 31, 2020:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of | ​ | As of | ​
(in millions) | ​ | March 31, 2021 | ​ | December 31, 2020 | ​
2.900% senior notes due June 1, 2030 | ​ | $ | 594 | ​ | $ | 594 | ​
3.200% senior notes due October 1, 2026 | ​ | ​ | 497 | ​ | ​ | 497 | ​
3.900% senior notes due June 1, 2050 | ​ | ​ | 390 | ​ | ​ | 390 | ​
6.625% senior notes due April 15, 2037 | ​ | ​ | 253 | ​ | ​ | 253 | ​
Revolving credit facility | ​ | ​ | — | ​ | ​ | — | ​
Other long-term borrowings | ​ | ​ | 15 | ​ | ​ | 14 | ​
Total long-term debt | ​ | ​ | 1,749 | ​ | ​ | 1,748 | ​
Term loan credit agreement due April 12, 2021 | ​ | ​ | — | ​ | ​ | 380 | ​
Amended term loan credit agreement due March 15, 2022 | ​ | ​ | 380 | ​ | ​ | — | ​
Other short-term borrowings | ​ | ​ | 68 | ​ | ​ | 58 | ​
Total short-term borrowings | ​ | ​ | 448 | ​ | ​ | 438 | ​
Total debt | ​ | $ | 2,197 | ​ | $ | 2,186 | ​

​

On March 16, 2021, the Company amended and restated its term loan credit agreement (the “Amended Term Loan Credit Agreement”). The Amended Term Loan Credit Agreement restates the previous agreement by extending the maturity date of the borrowings under the previous agreement until March 15, 2022. No new borrowings under the Amended Term Loan Credit Agreement were incurred in connection with the amendment and restatement. Borrowings under the Amended Term Loan Credit Agreement bear interest at a variable annual rate based on London Interbank Offering Rate (“LIBOR”) or a base rate, at the Company’s election, subject to the terms and conditions thereof, plus, in each case, an applicable margin. The Amended Term Loan Credit Agreement reduces the applicable interest rate margin for loans accruing interest based on LIBOR from 0.80 percent to 0.75 percent. The Company is required to pay a fee on the unused availability under the Amended Term Loan Credit Agreement. The Amended Term Loan Credit Agreement contains customary representations, warranties, covenants and events of default, including covenants restricting the incurrence of liens, the incurrence of indebtedness by the Company’s subsidiaries and certain fundamental changes involving the Company and its subsidiaries, subject to certain exceptions in each case. The Company must also maintain a specified maximum consolidated leverage ratio and a specified minimum consolidated interest coverage ratio. As of March 31, 2021, the Company was in compliance with these financial covenants. The occurrence of an event of default under the Amended Term Loan Credit Agreement could result in all loans and other obligations being declared due and payable and the term loan credit facility being terminated.

​

Other short-term borrowings as of March 31, 2021 and December 31, 2020, primarily include amounts outstanding under various unsecured local country operating lines of credit.

​

8. Leases

​

The Company determines if an arrangement is a lease at inception of the agreement. Operating leases are included in operating lease assets, and current and non-current operating lease liabilities in the Company’s Condensed Consolidated Balance Sheets. Lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease asset value includes in its calculation any prepaid lease payments made and any lease incentives received from the arrangement as a reduction of the asset. The Company’s lease terms may include options to extend or terminate the lease, and the impact of these options is included in the lease liability and lease asset calculations when the exercise of the option is at the Company’s sole discretion and it is reasonably certain that the Company will exercise that option. The Company will not separate lease and non-lease

16

Table of Contents

components for its leases when it is impracticable to separate the two, such as for leases with variable payment arrangements. Leases with an initial term of 12 months or less are not recorded on the balance sheet.

​

The Company has operating leases for certain rail cars, office space, warehouses, and machinery and equipment. The commencement date used for the calculation of the lease obligations recorded is the latter of the commencement date of the new standard (January 1, 2019) or the lease start date. Certain of the leases have options to extend the life of the lease, which are included in the liability calculation when the option is at the sole discretion of the Company and it is reasonably certain that the Company will exercise the option. The Company has certain leases that have variable payments based solely on output or usage of the leased asset. These variable operating lease assets are excluded from the Company’s balance sheet presentation and expensed as incurred. The Company currently has no finance leases.

​

Lease expense for lease payments is recognized on a straight-line basis over the lease term. The components of lease expense were as follows for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
Lease Cost | ​ | March 31, | ​
(in millions) | ​ | 2021 |  | 2020 | ​
Operating lease cost | ​ | $ | 14 | ​ | $ | 13 | ​
Variable operating lease cost | ​ | ​ | 7 | ​ | ​ | 8 | ​
Short term lease cost | ​ | ​ | 1 | ​ | ​ | 1 | ​
Lease cost | ​ | $ | 22 | ​ | $ | 22 | ​

​

The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities and the related operating lease assets as presented on the Condensed Consolidated Balance Sheet as of March 31, 2021.

​

​

​ | ​ | ​ | ​ | ​
Operating Leases | ​ | ​ | As of | ​
(in millions) | ​ | ​ | March 31, 2021 | ​
2021 (Excluding the three months ended March 31, 2021) | ​ | $ | 39 | ​
2022 | ​ | ​ | 45 | ​
2023 | ​ | ​ | 35 | ​
2024 | ​ | ​ | 25 | ​
2025 | ​ | ​ | 17 | ​
Thereafter | ​ | ​ | 53 | ​
Total future lease payments | ​ | ​ | 214 | ​
Less imputed interest | ​ | ​ | 24 | ​
Present value of future lease payments | ​ | ​ | 190 | ​
Less current lease liabilities | ​ | ​ | 45 | ​
Non-current operating lease liabilities | ​ | $ | 145 | ​
Operating lease assets | ​ | $ | 182 | ​

​

Additional information related to the Company’s operating leases is listed below.

​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
Other Information | ​ | March 31, | ​
($ in millions) |  | 2021 |  | 2020 | ​
Cash paid for amounts included in the measurement of lease liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating cash flows from operating leases | ​ | $ | 14 | ​ | $ | 13 | ​
Right-of-use assets obtained in exchange for lease liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating leases | ​ | $ | 21 | ​ | $ | 8 | ​
​ | ​ | As of | ​ | As of | ​
​ | ​ | March 31, 2021 | ​ | December 31, 2020 | ​
Weighted average remaining lease term: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating leases | ​ | ​ | 6.3 years | ​ | ​ | 5.5 years | ​
Weighted average discount rate: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating leases | ​ | ​ | 4.6 | % | ​ | 4.9 | %

​

​

​

​

17

Table of Contents

9. Taxes

​

The Company’s effective tax rate for the three months ended March 31, 2021 was (29.3) percent compared to 42.6 percent for the three months ended March 31, 2020. The primary change in the effective tax rate was driven by the $360 million impairment related to the held for sale treatment of net assets that will be contributed to the joint venture, as described in Note 5 of the Notes to the Condensed Consolidated Financial Statements. There was no corresponding income tax benefit recorded with respect to the impairment. The remaining decrease in the effective income tax rate compared to the three months ended March 31, 2020, was driven by the relatively lower decrease in value of the Mexican peso against the U.S. dollar and a reduction in the Company’s U.S. global intangible low-taxed income (“GILTI”) recorded in accordance with the applicable final U.S. Treasury regulations. During the three months ended March 31, 2020, the Mexican peso decreased in value against the U.S. dollar by 24 percent, compared to 3 percent during the three months ended March 31, 2021. Because the Company uses the U.S. dollar as the functional currency for its subsidiaries in Mexico, its effective income tax rate is strongly influenced by the remeasurement of the Mexican peso financial statements into U.S. dollars. In addition, the decrease in value of the Mexican peso produced substantial taxable translation gains on net-U.S.-dollar-monetary assets held in Mexico, for which there was no corresponding gain in pre-tax income. These items were partially offset by a change in the mix of earnings and including the consolidation of PureCircle and Verdient from their respective dates, as described in Note 3 of the Notes to the Condensed Consolidated Financial Statements.

​

10. Net Periodic Pension and Postretirement Benefit Costs

​

The following table sets forth the components of net periodic benefit cost of the U.S. and non-U.S. defined benefit pension plans for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​
​ | ​ | U.S. Plans | ​ | Non-U.S. Plans | ​
(in millions) |  | 2021 |  | 2020 |  | 2021 |  | 2020 |
Service cost | ​ | $ | 1 | ​ | $ | 1 | ​ | $ | 1 | ​ | $ | 1 | ​
Interest cost | ​ | ​ | 2 | ​ | ​ | 3 | ​ | ​ | 3 | ​ | ​ | 3 | ​
Expected return on plan assets | ​ | ​ | (5) | ​ | ​ | (5) | ​ | ​ | (2) | ​ | ​ | (2) | ​
Amortization of actuarial loss | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 1 | ​ | ​ | — | ​
Net periodic benefit cost (a) | ​ | $ | (2) | ​ | $ | (1) | ​ | $ | 3 | ​ | $ | 2 | ​

​

The Company currently anticipates that it will make approximately $4 million in cash contributions to its pension plans in 2021, consisting of contributions of $3 million to its non-U.S. pension plans and $1 million to its U.S. pension plans. For the three months ended March 31, 2021, cash contributions of approximately $1 million were made to the non-U.S. plans and an insignificant amount to the U.S. plans.

​

The following table sets forth the components of net postretirement benefit cost for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​
(in millions) |  | 2021 |  | 2020 | ​
Service cost | ​ | $ | — | ​ | $ | — | ​
Interest cost | ​ | ​ | 1 | ​ | ​ | 1 | ​
Amortization of prior service credit | ​ | ​ | (1) | ​ | ​ | (1) | ​
Net periodic benefit cost (a) | ​ | $ | — | ​ | $ | — | ​

| (a) | The service cost component of net periodic benefit cost is presented within either cost of sales or operating expenses on the Condensed Consolidated Statements of (Loss) Income. The interest cost, expected return on plan assets, amortization of prior service credit, and amortization of actuarial loss components of net periodic benefit cost are presented as other, non-operating income on the Condensed Consolidated Statements of (Loss) Income.

​

18

Table of Contents

​

11. Inventories

​

Inventories are summarized as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of | ​ | As of |
(in millions) |  | March 31, 2021 |  | December 31, 2020 |
Finished and in process |  | $ | 573 |  | $ | 584 | ​
Raw materials | ​ |  | 283 | ​ |  | 236 | ​
Manufacturing supplies and other | ​ |  | 94 | ​ |  | 97 | ​
Total inventories |  | $ | 950 |  | $ | 917 | ​

​

​

12. Equity

​

Treasury stock: On October 22, 2018, the Board of Directors authorized a new stock repurchase program permitting the Company to purchase up to 8 million of its outstanding shares of common stock from November 5, 2018 through December 31, 2023. The parameters of the Company’s stock repurchase program are not established solely with reference to the dilutive impact of shares issued under the Company’s stock incentive plan. However, the Company expects that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan.

​

During the three months ended March 31, 2021, the Company repurchased 158 thousand outstanding shares of common stock in open market transactions at a net cost of $14 million. During the three months ended March 31, 2020, the Company did not repurchase shares of common stock.

​

Share-based payments: The following table summarizes the components of the Company’s share-based compensation expense for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions) |  | 2021 |  | 2020 |
Stock options: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pre-tax compensation expense |  | $ | 1 | ​ | $ | 1 | ​
Income tax benefit | ​ |  | — | ​ |  | — | ​
Stock option expense, net of income taxes | ​ |  | 1 | ​ |  | 1 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Restricted stock units ("RSUs"): | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pre-tax compensation expense | ​ |  | 3 | ​ |  | 3 | ​
Income tax benefit | ​ |  | — | ​ |  | (1) | ​
RSUs, net of income taxes | ​ |  | 3 | ​ |  | 2 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Performance shares and other share-based awards: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pre-tax compensation expense | ​ |  | 1 | ​ |  | 2 | ​
Income tax benefit | ​ |  | — | ​ |  | — | ​
Performance shares and other share-based compensation expense, net of income taxes | ​ |  | 1 | ​ |  | 2 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total share-based compensation: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Pre-tax compensation expense | ​ |  | 5 | ​ |  | 6 | ​
Income tax benefit | ​ |  | — | ​ |  | (1) | ​
Total share-based compensation expense, net of income taxes |  | $ | 5 | ​ | $ | 5 | ​

​

Stock Options: Under the Company’s stock incentive plan, stock options are granted at exercise prices that equal the market value of the underlying common stock on the date of grant. The options have a 10-year term and are exercisable upon vesting, which occurs over a three-year period at the anniversary dates of the date of grant. Compensation expense is generally recognized on a straight-line basis for all awards over the employee’s vesting period or over a one-year required service period for certain retirement-eligible executive level employees. The Company estimates a forfeiture rate

19

Table of Contents

at the time of grant and updates the estimate throughout the vesting period of the stock options within the amount of compensation costs recognized in each period.

​

The Company granted non-qualified options to purchase 358 thousand shares and 336 thousand shares for the three months ended March 31, 2021 and 2020, respectively. The fair value of each option grant for the periods presented was estimated using the Black-Scholes option-pricing model with the following assumptions at the date of grant:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​
​ |  | 2021 | ​ | 2020 | ​
Expected life (in years) | ​ | 5.5 | ​ | ​ | 5.5 | ​ | ​
Risk-free interest rate | ​ | 0.6 | % | ​ | 1.4 | % |
Expected volatility | ​ | 23.2 | % | ​ | 19.8 | % | ​
Expected dividend yield | ​ | 2.9 | % | ​ | 2.9 | % | ​

​

The expected life of options represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and the Company’s historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of the Company’s common stock. Dividend yield is based on current dividend payments at the date of grant.

​

Stock option activity for the three months ended March 31, 2021 was as follows:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Number of Options (in thousands) |  | Weighted Average Exercise Price per Share |  | Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value (in millions) |
Outstanding as of December 31, 2020 |  | 2,238 |  | $ | 86.55 | ​ | 5.15 | ​ | $ | 14 | ​
Granted |  | 358 | ​ | ​ | 87.12 | ​ | ​ | ​ | ​ | ​ | ​
Exercised |  | (154) | ​ | ​ | 56.35 | ​ | ​ | ​ | ​ | ​ | ​
Cancelled |  | (27) | ​ | ​ | 94.39 | ​ | ​ | ​ | ​ | ​ | ​
Outstanding as of March 31, 2021 |  | 2,415 | ​ | $ | 88.68 |  | 5.89 |  | $ | 20 | ​
Exercisable as of March 31, 2021 |  | 1,775 | ​ | $ | 88.90 |  | 4.66 |  | $ | 19 | ​

​

For the three months ended March 31, 2021, cash received from the exercise of stock options was approximately $9 million. As of March 31, 2021, the unrecognized compensation cost related to non-vested stock options totaled $6 million, which is expected to be amortized over the weighted-average period of approximately 1.9 years.

​

Additional information pertaining to stock option activity is as follows for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(dollars in millions, except per share) |  | 2021 |  | 2020 |
Weighted average grant date fair value of stock options granted (per share) | ​ | $ | 12.31 | ​ | $ | 11.48 | ​
Total intrinsic value of stock options exercised | ​ | $ | 5 | ​ | $ | 4 | ​

​

Restricted Stock Units: The Company has granted restricted stock units (“RSUs”) to certain key employees. The RSUs are primarily subject to cliff vesting, generally after three years, provided the employee remains in the service of the Company. Compensation expense is generally recognized on a straight-line basis for all awards over the employee’s vesting period or over a one-year required service period for certain retirement-eligible executive level employees. The Company estimates a forfeiture rate at the time of grant and updates the estimate throughout the vesting period of the RSUs within the amount of compensation costs recognized in each period. The fair value of the RSUs is determined based upon the number of shares granted and the market price of the Company’s common stock on the date of the grant.

​

20

Table of Contents

The following table summarizes RSU activity for the three months ended March 31, 2021:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
(RSUs in thousands) |  | Number of Restricted Shares |  | Weighted Average Fair Value per Share | ​
Non-vested as of December 31, 2020 | ​ | 418 | ​ | $ | 96.45 | ​
Granted | ​ | 214 | ​ | ​ | 87.25 | ​
Vested | ​ | (83) | ​ | ​ | 126.67 | ​
Cancelled | ​ | (12) | ​ | ​ | 91.19 | ​
Non-vested as of March 31, 2021 | ​ | 537 | ​ | $ | 88.28 | ​

​

As of March 31, 2021, the total remaining unrecognized compensation cost related to RSUs was $30 million, which will be amortized over a weighted average period of approximately 2.2 years.

​

Performance Shares: The Company has a long-term incentive plan for senior management in the form of performance shares. Historically these performance shares vested based solely on the Company’s total shareholder return as compared to the total shareholder return of its peer group over the three-year vesting period. Beginning with the 2019 performance share grants, the vesting of the performance shares is based on two performance metrics. Fifty percent of the performance shares awarded will vest based on the Company’s total shareholder return as compared to the total shareholder return of its peer group, and the remaining fifty percent will vest based on the calculation of the Company’s three-year average Adjusted Return on Invested Capital (“Adjusted ROIC”) against an established Adjusted ROIC target. The 2021 performance shares were granted in two tranches. The first tranche was split evenly between awards based on the Company’s total shareholder return and Adjusted ROIC awards. The second tranche of performance share awards will vest 100% based on the calculation of Adjusted ROIC against the target.

​

For the 2021 performance shares awarded based on the Company’s total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the awarded grant depending on the Company’s total shareholder return as compared to the total shareholder return of its peer group. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. The total compensation expense for these awards is amortized over a three-year graded vesting schedule.

​

For the 2021 performance shares awarded based on Adjusted ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the awarded grant depending on the Company’s Adjusted ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. Compensation expense is based on the market price of the Company’s common stock on the date of the grant and the final number of shares that ultimately vest. The Company will estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect the Company’s estimated Adjusted ROIC performance against the target. The total compensation expense for these awards is amortized over a three-year graded vesting schedule.

​

For the three months ended March 31, 2021, the Company awarded 108 thousand performance shares at a weighted average fair value of $100.29 per share.

​

As of March 31, 2021, the unrecognized compensation cost related to these awards was $12 million, which will be amortized over the remaining requisite service period of 2.5 years.

​

The 2018 performance share awards vested during the three months ended March 31, 2021, achieving a zero percent payout of the granted performance shares. Additionally, there were 2 thousand performance share cancellations during the three months ended March 31, 2021.

​

​

21

Table of Contents

Accumulated Other Comprehensive Loss: The following is a summary of net changes in Accumulated other comprehensive loss by component and net of tax for the three months ended March 31, 2021 and 2020:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(in millions) |  | Cumulative Translation Adjustment |  | Hedging Activities |  | Pension and Postretirement Adjustment |  | Accumulated Other Comprehensive Loss |
Balance, December 31, 2020 | ​ | $ | (1,114) | ​ | $ | 42 | ​ | $ | (61) | ​ | $ | (1,133) | ​
Other comprehensive (loss) gain before reclassification adjustments | ​ | ​ | (52) | ​ | ​ | 29 | ​ | ​ | — | ​ | ​ | (23) | ​
(Gain) reclassified from accumulated OCL | ​ | ​ | — | ​ | ​ | (1) | ​ | ​ | — | ​ | ​ | (1) | ​
Tax (provision) | ​ | ​ | — | ​ | ​ | (7) | ​ | ​ | — | ​ | ​ | (7) | ​
Net other comprehensive (loss) income | ​ | ​ | (52) | ​ | ​ | 21 | ​ | ​ | — | ​ | ​ | (31) | ​
Balance, March 31, 2021 | ​ | $ | (1,166) | ​ | $ | 63 | ​ | $ | (61) | ​ | $ | (1,164) | ​

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(in millions) |  | Cumulative Translation Adjustment |  | Hedging Activities |  | Pension and Postretirement Adjustment |  | Accumulated Other Comprehensive Loss |
Balance, December 31, 2019 | ​ | $ | (1,089) | ​ | $ | (9) | ​ | $ | (60) | ​ | $ | (1,158) | ​
Other comprehensive (loss) before reclassification adjustments | ​ | ​ | (134) | ​ | ​ | (46) | ​ | ​ | — | ​ | ​ | (180) | ​
Loss reclassified from accumulated OCL | ​ | ​ | — | ​ | ​ | 6 | ​ | ​ | — | ​ | ​ | 6 | ​
Tax benefit | ​ | ​ | — | ​ | ​ | 10 | ​ | ​ | — | ​ | ​ | 10 | ​
Net other comprehensive loss | ​ | ​ | (134) | ​ | ​ | (30) | ​ | ​ | — | ​ | ​ | (164) | ​
Balance, March 31, 2020 | ​ | $ | (1,223) | ​ | $ | (39) | ​ | $ | (60) | ​ | $ | (1,322) | ​

​

Supplemental Information: The following Condensed Consolidated Statements of Equity and Redeemable Equity provide the dividends per share for common stock for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Total Equity | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Non- | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​ | ​ | Redeemable | Share-based | ​ | Redeemable | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Other | ​ | ​ | ​ | ​ | Non- | ​ | Payments | ​ | Non- | ​
​ | ​ | Preferred | ​ | Common | ​ | Paid-In | ​ | Treasury | ​ | Comprehensive | ​ | Retained | ​ | Controlling | ​ | Subject to | ​ | Controlling | ​
(in millions) |  | Stock |  | Stock |  | Capital |  | Stock |  | Loss |  | Earnings |  | Interests |  | Redemption |  | Interests |
Balance, December 31, 2020 | ​ | $ | — | ​ | $ | 1 | ​ | $ | 1,150 | ​ | $ | (1,024) | ​ | $ | (1,133) | ​ | $ | 3,957 | ​ | $ | 21 | ​ | $ | 30 | ​ | $ | 70 | ​
Net (loss) attributable to Ingredion | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (246) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income attributable to non-controlling interests | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 4 | ​ | ​ | ​ | ​ | ​ | (1) | ​
Dividends declared, common stock ($0.64/share) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (44) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Repurchases of common stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (14) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Share-based compensation, net of issuance | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 5 | ​ | ​ | 16 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (9) | ​ | ​ | ​ | ​
Other comprehensive loss | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (31) | ​ | ​ | ​ | ​ | ​ | 1 | ​ | ​ | ​ | ​ | ​ | 1 | ​
Balance, March 31, 2021 | ​ | $ | — | ​ | $ | 1 | ​ | $ | 1,155 | ​ | $ | (1,022) | ​ | $ | (1,164) | ​ | $ | 3,667 | ​ | $ | 26 | ​ | $ | 21 | ​ | $ | 70 | ​

​

22

Table of Contents

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Total Equity | ​ | ​ | ​ | ​ | ​ | ​ |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Non- | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Accumulated | ​ | ​ | ​ | ​ | Redeemable | Share-based | ​ | Redeemable |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Other | ​ | ​ | ​ | ​ | Non- | ​ | Payments | ​ | Non- | ​
​ | ​ | Preferred | ​ | Common | ​ | Paid-In | ​ | Treasury | ​ | Comprehensive | ​ | Retained | ​ | Controlling | ​ | Subject to | ​ | Controlling |
(in millions) |  | Stock |  | Stock |  | Capital |  | Stock |  | Loss |  | Earnings |  | Interests |  | Redemption |  | Interests |
Balance, December 31, 2019 | ​ | $ | — | ​ | $ | 1 | ​ | $ | 1,137 | ​ | $ | (1,040) | ​ | $ | (1,158) | ​ | $ | 3,780 | ​ | $ | 21 | ​ | $ | 31 | ​ | $ | — | ​
Net income attributable to Ingredion | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 75 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income attributable to non-controlling interests | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 3 | ​ | ​ | ​ | ​ | ​ | ​ | ​
Dividends declared, common stock ($0.63/share) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (42) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Repurchases of common stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Share-based compensation, net of issuance | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 5 | ​ | ​ | 12 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (8) | ​ | ​ | ​ | ​
Other comprehensive loss | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (164) | ​ | ​ | ​ | ​ | ​ | (3) | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balance, March 31, 2020 | ​ | $ | — | ​ | $ | 1 | ​ | $ | 1,142 | ​ | $ | (1,028) | ​ | $ | (1,322) | ​ | $ | 3,813 | ​ | $ | 21 | ​ | $ | 23 | ​ | $ | — | ​

​

Supplemental Information: The following table provides the computation of basic and diluted earnings per common share ("EPS") for the periods presented:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
| ​ | Three Months Ended March 31, 2021 |  | Three Months Ended March 31, 2020 |
(in millions, except per share amounts) |  | Net Income Available to Ingredion |  | Weighted Average Shares |  | Per Share Amount |  | Net Income Available to Ingredion |  | Weighted Average Shares |  | Per Share Amount |
Basic EPS | ​ | $ | (246) |  | 67.3 | ​ | $ | (3.66) | ​ | $ | 75 |  | 67.1 | ​ | $ | 1.12 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Effect of Dilutive Securities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards | ​ | ​ | ​ |  | — | ​ | ​ | ​ | ​ | ​ | ​ |  | 0.7 | ​ | ​ | ​ | ​
Diluted EPS | ​ | $ | (246) |  | 67.3 | ​ | $ | (3.66) | ​ | $ | 75 |  | 67.8 | ​ | $ | 1.11 | ​

​

Approximately 2.1 million and 1.5 million share-based awards of common stock were excluded from the calculation of diluted EPS as the impact of their inclusion would have been anti-dilutive for the three months ended March 31, 2021 and 2020, respectively.

​

13. Segment Information

​

The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s operations are classified into four reportable business segments: North America, South America, Asia-Pacific, and EMEA. Its North America segment includes businesses in the U.S., Mexico, and Canada. The Company’s South America segment includes businesses in Brazil, Colombia, Ecuador, and the Southern Cone of South America, which includes Argentina, Peru, Chile, and Uruguay. Its Asia-Pacific segment includes businesses in South Korea, Thailand, China, Australia, Japan, Indonesia, Singapore, the Philippines, India, Malaysia, New Zealand, and Vietnam. The Company’s EMEA segment includes businesses in Pakistan, Germany, the United Kingdom, South Africa, and Kenya. The Company has aggregated the PureCircle operating segment into the Asia-Pacific reportable segment. Net sales by product are not presented because to do so would be impracticable.

​

23

Table of Contents

Presented below are the Company’s net sales to unaffiliated customers by reportable segment for the three months ended March 31, 2021 and 2020.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions) |  | 2021 |  | 2020 |
Net sales to unaffiliated customers: | ​ | ​ | ​ | ​ | ​ | ​ | ​
North America | ​ | $ | 945 | ​ | $ | 963 | ​
South America | ​ | ​ | 273 | ​ | ​ | 237 | ​
Asia-Pacific | ​ | ​ | 235 | ​ | ​ | 189 | ​
EMEA | ​ | ​ | 161 | ​ | ​ | 154 | ​
Total net sales | ​ | $ | 1,614 | ​ | $ | 1,543 | ​

​

Presented below is the Company’s operating income by reportable segment for the three months ended March 31, 2021, and 2020.

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​
​ | ​ | March 31, | ​
(in millions) | ​ | 2021 | ​ | 2020 | ​
Operating income: | ​ | ​ | ​ | ​ | ​ | ​ | ​
North America | ​ | $ | 134 | ​ | $ | 125 | ​
South America | ​ | ​ | 40 | ​ | ​ | 26 | ​
Asia-Pacific | ​ | ​ | 25 | ​ | ​ | 20 | ​
EMEA | ​ | ​ | 31 | ​ | ​ | 27 | ​
Corporate | ​ | ​ | (29) | ​ | ​ | (31) | ​
Subtotal | ​ | ​ | 201 | ​ | ​ | 167 | ​
Acquisition/integration costs | ​ | ​ | (1) | ​ | ​ | — | ​
Restructuring/impairment charges | ​ | ​ | (10) | ​ | ​ | (14) | ​
Impairment charges related to assets classified as held for sale | ​ | ​ | (360) | ​ | ​ | — | ​
Total operating income | ​ | $ | (170) | ​ | $ | 153 | ​

​

Presented below are the Company’s total assets by reportable segment as of March 31, 2021, and December 31, 2020.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of | ​ | As of | ​
(in millions) |  | March 31, 2021 |  | December 31, 2020 | ​
Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​
North America (a) | ​ | $ | 4,240 | ​ | $ | 4,231 | ​
South America | ​ | ​ | 751 | ​ | ​ | 818 | ​
Asia-Pacific | ​ | ​ | 1,257 | ​ | ​ | 1,255 | ​
EMEA | ​ | ​ | 555 | ​ | ​ | 554 | ​
Total assets | ​ | $ | 6,803 | ​ | $ | 6,858 | ​

| (a) | For purposes of presentation, North America includes Corporate assets.

​

​

​

14. Subsequent Events

​

On April 1, 2021, the Company acquired KaTech, a privately-held company headquartered in Germany. KaTech provides advanced texture and stabilization solutions to the food and beverage industry. To complete the purchase, the Company made a total cash payment of EUR 36 million ($42 million), which it funded from cash on hand. KaTech’s operational results will be recorded in the EMEA segment.

​

On May 3, 2021, the Company signed an agreement with Amyris to enter into an exclusive license to sell Amyris, Inc.’s zero-calorie, nature-based, fermented Reb M sweetener. Additionally, the Company will obtain a 31 percent ownership in Amyris, Inc.’s Brazilian manufacturing facility. The transaction is expected to close during the second quarter of 2021.

​

​

​

24

Table of Contents

ITEM 2

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

​

Unless the context indicates otherwise, references to “we,” “us,” “our,” the “Company” and “Ingredion” mean Ingredion Incorporated and its consolidated subsidiaries.

​

Overview

​

We are a major supplier of high-quality food and industrial ingredient solutions to customers around the world. As of March 31, 2021, we have 46 manufacturing facilities located in North America, South America, Asia-Pacific and Europe, the Middle East and Africa (“EMEA”), and we manage and operate our businesses at a regional level. We believe this approach provides us with a unique understanding of the cultures and product requirements in each of the geographic markets in which we operate, bringing added value to our customers. Our ingredients are used by customers in the food, beverage, brewing, and animal nutrition industries, among others.

​

Our strategic growth roadmap is based on five growth platforms and is designed to deliver shareholder value by accelerating customer co-creation and enabling consumer-preferred innovation. Our first platform is starch-based texturizers, the second platform is clean and simple ingredients, the third platform is plant-based proteins, the fourth platform is sugar reduction and specialty sweeteners, and finally, our fifth platform is value-added food systems.

​

For the three months ended March 31, 2021, operating income, net income and diluted earnings per share decreased from the comparable 2020 period. The decreases for this period were primarily attributable to a $360 million held for sale impairment charge related to the Arcor joint venture in Argentina discussed below, including the write off of $311 million of cumulative translation losses.

​

COVID-19: Our operations in recent periods have been adversely affected by impacts of the coronavirus disease 2019 (“COVID-19”) pandemic. Our global operations expose us to risks associated with public health crises such as COVID-19. Foreign governmental organizations and governmental organizations at the national, state and local levels in the United States have taken various actions to combat the spread of COVID-19, including imposing stay-at-home orders and closing “non-essential” businesses and their operations. As a manufacturer of food ingredients, our operations are considered “essential” under most current COVID-19 government regulations, and our facilities are operating globally. We did not experience any material supply chain interruptions during the three months ended March 31, 2021, and were able to continue to operate and ship products from our global network of manufacturing facilities. We place top priority on our employees’ health and safety and continue to follow the advice and the guidelines of public health authorities for physical distancing and to make available personal protective equipment and sanitization supplies. We continue to monitor COVID-19 infection rates as well as the pace and effectiveness of vaccination rollouts, as the net sales volume is generally correlated with increased consumer activity and availability of food and beverages consumed away from home.

​

Impairment Charges: On February 12, 2021, we signed an agreement with Grupo Arcor, an Argentine food company, to establish a joint venture to combine manufacturing operations in Argentina in order to sell value-added ingredients to customers in Argentina, Chile and Uruguay. In connection with our entry into the joint venture agreement, we classified the assets and liabilities to be transferred to the joint venture as held for sale in our Condensed Consolidated Financial Statements during the three months ended March 31, 2021. Accordingly, we recorded those assets and liabilities at fair value, less estimated transaction costs, resulting in an impairment charge of $360 million, of which $311 million was related to the required valuation allowance of the cumulative translation losses associated with the contributed net assets and $49 million was related to the write-down of the contributed net assets to the agreed upon fair value. The non-cash impairment charge is subject to finalization based on ending balances and foreign exchange impacts until the transaction closes. We recorded the impairment within Restructuring/impairment charges in the Condensed Consolidated Statements of (Loss) Income for the three months ended March 31, 2021 included in this report. The assets and liabilities held for sale are recorded in our Condensed Consolidated Balance Sheets as of March 31, 2021 included in this report in Other assets and Liabilities held for sale, respectively. The assets and liabilities held for sale were classified under our South America reportable business segment.

​

Restructuring Charges: In July 2018, we announced a $125 million savings target for our Cost Smart program, designed to improve profitability, further streamline our global business, and deliver increased value to stockholders. We set Cost Smart savings targets to include an anticipated $75 million in Cost of sales savings, including freight, and $50

25

Table of Contents

million in anticipated SG&A savings by year-end 2021. Since the program’s inception, we have periodically updated our savings targets and we now expect to deliver $170 million in total savings by year-end 2021.

​

Our Cost Smart program and other initiatives have resulted in restructuring charges. For the three months ended March 31, 2021, we recorded a total of $8 million of pre-tax restructuring charges related to these programs, a decrease of $6 million from the restructuring charges recorded during the three months ended March 31, 2020. We recorded $5 million of restructuring charges related for our Cost Smart SG&A program, primarily related to professional service costs in North America during the three months ended March 31, 2021, and $3 million of restructuring charges for our Cost Smart Cost of sales program, primarily related to the reorganization of North America’s supply chain during the three months ended March 31, 2021.

​

Liquidity and Capital Resources: Our cash provided by operating activities decreased to $22 million for the three months ended March 31, 2021, from $65 million for the prior year, primarily due to changes in our working capital. Our cash used for investing activities decreased to $64 million for the three months ended March 31, 2021, from $96 million for the prior year, primarily as a result of the timing of capital expenditures and mechanical stores purchases. Our cash used for financing activities was $40 million during the three months ended March 31, 2021, compared to cash provided by financing activities of $62 million in the prior year. This decrease was mainly driven by lower net borrowings during the current period, as well as the repurchase of 158 thousand outstanding shares of common stock at a net cost of $14 million during the period.

​

Results of Operations

​

We have significant operations in four reporting segments: North America, South America, Asia-Pacific and EMEA. For most of our foreign subsidiaries, the local foreign currency is the functional currency. Accordingly, revenues and expenses denominated in the functional currencies of these subsidiaries are translated into U.S. dollars at the applicable average exchange rates for the period. Fluctuations in foreign currency exchange rates affect the U.S. dollar amounts of our foreign subsidiaries’ revenues and expenses. The impact of foreign currency translation to the reporting currency, where significant, is provided below.

​

We acquired a controlling interest in PureCircle on July 1, 2020 and Verdient on November 3, 2020. The results of the acquired businesses are included in our consolidated financial results from the respective acquisition dates. While we identify the effects of the acquisitions, our discussion below also addresses results of operations excluding the impact of the acquisitions and the results of the acquired businesses, where appropriate, to provide a more comparable analysis.

​

26

Table of Contents

For the Three Months Ended March 31, 2021

With Comparatives for the Three Months Ended March 31, 2020

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​ | Favorable (Unfavorable) | ​ | Favorable (Unfavorable) | ​
(in millions) |  | 2021 |  | 2020 |  | Variance | ​ | Percentage | ​
Net sales | ​ | $ | 1,614 | ​ | $ | 1,543 | ​ | $ | 71 | ​ | 5 | %
Cost of sales | ​ | ​ | 1,263 | ​ | ​ | 1,220 | ​ | ​ | (43) | ​ | (4) | %
Gross profit | ​ | ​ | 351 | ​ | ​ | 323 | ​ | ​ | 28 | ​ | 9 | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating expenses | ​ | ​ | 153 | ​ | ​ | 154 | ​ | ​ | 1 | ​ | 1 | %
Other (income) expense, net | ​ | ​ | (2) | ​ | ​ | 2 | ​ | ​ | 4 | ​ | 200 | %
Restructuring/impairment charges | ​ | ​ | 370 | ​ | ​ | 14 | ​ | ​ | (356) | ​ | (2,543) | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating (loss) income | ​ | ​ | (170) | ​ | ​ | 153 | ​ | ​ | (323) | ​ | (211) | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Financing costs, net | ​ | ​ | 19 | ​ | ​ | 18 | ​ | ​ | (1) | ​ | (6) | %
Other, non-operating (income), net | ​ | ​ | (1) | ​ | ​ | (1) | ​ | ​ | — | ​ | — | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(Loss) income before income taxes | ​ | ​ | (188) | ​ | ​ | 136 | ​ | ​ | (324) | ​ | (238) | %
Provision for income taxes | ​ | ​ | 55 | ​ | ​ | 58 | ​ | ​ | 3 | ​ | 5 | %
Net (loss) income | ​ | ​ | (243) | ​ | ​ | 78 | ​ | ​ | (321) | ​ | (412) | %
Less: Net income attributable to non-controlling interests | ​ | ​ | 3 | ​ | ​ | 3 | ​ | ​ | — | ​ | — | %
Net (loss) income attributable to Ingredion | ​ | $ | (246) | ​ | $ | 75 | ​ | $ | (321) | ​ | (428) | %

​

Net income attributable to Ingredion. Net income attributable to Ingredion for the three months ended March 31, 2021, decreased by 428 percent to $(246) million from $75 million for the three months ended March 31, 2020. The decrease in net income was largely attributable to an impairment charge taken for the held for sale treatment of certain net assets that will be contributed to the Arcor joint venture in Argentina as described in Note 5 of the Notes to the Consolidated Financial Statements included in this report. The effect of this charge was partially offset by favorable price mix in South America and net corn costs in North America.

​

Net sales. Net sales increased $71 million or 5 percent for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020. The increase was driven by price mix, including the pass through of higher corn costs, the inclusion or PureCircle results, and specialty volume growth in Asia-Pacific.

​

Cost of sales. Cost of sales for the three months ended March 31, 2021 increased by $43 million or 4 percent as compared to the three months ended March 31, 2020. Our gross profit margin increased by 1 percent, from 21 percent for the three months ended March 31, 2020 to 22 percent for the three months ended March 31, 2021. The increase in gross profit margin was mainly attributable to favorable price and product mix.

​

Operating expenses. Our operating expenses decreased 1 percent to $153 million for the three months ended March 31, 2021 as compared to $154 million for the three months ended March 31, 2020. Operating expenses, as a percentage of net sales, were 10 percent for the three months ended March 31, 2021 and the three months ended March 31, 2020.

​

Financing costs, net. Financing costs for the three months ended March 31, 2021 increased to $19 million from $18 million for the three months ended March 31, 2020. The increase was driven primarily by lower capitalized interest on capital projects for the three months ended March 31, 2021.

​

Provision for income taxes. Our effective tax rate for the three months ended March 31, 2021 was (29.3) percent compared to 42.6 percent for the three months ended March 31, 2020. The change in the effective tax rate was driven by the $360 million impairment related to the held for sale treatment of net assets that will be contributed to the Arcor joint venture in Argentina. There was no corresponding income tax benefit recorded with respect to the impairment. Without the impairment recorded the effective tax rate for the three months ended March 31, 2021 would have been 32.0 percent. The decrease in the effective income tax rate compared to the three months ended March 31, 2020, was driven by the

27

Table of Contents

relatively lower decrease in value of the Mexican peso against the U.S. dollar and a reduction in the Company’s U.S. global intangible low-taxed income (“GILTI”) recorded in accordance with the applicable final U.S. Treasury regulations. During the three months ended March 31, 2020, the Mexican peso decreased in value against the U.S. dollar by 24 percent, compared to 3 percent during the three months ended March 31, 2021. Because the Company uses the U.S. dollar as the functional currency for its subsidiaries in Mexico, its effective income tax rate is strongly influenced by the remeasurement of the Mexican peso financial statements into U.S. dollars. In addition, the decrease in value of the Mexican peso produced substantial taxable translation gains on net-U.S.-dollar-monetary assets held in Mexico, for which there was no corresponding gain in pre-tax income. These items were partially offset by a change in the mix of earnings and inclusion of the consolidation of PureCircle and Verdient from their respective dates, as described in Note 3 of the Notes to the Condensed Consolidated Financial Statements included in this report.

​

Segment Results

​

North America

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​ | Favorable (Unfavorable) | ​ | Favorable (Unfavorable) | ​
(in millions) |  | 2021 |  | 2020 |  | Variance |  | Percentage | ​
Net sales to unaffiliated customers | ​ | $ | 945 | ​ | $ | 963 | ​ | $ | (18) | ​ | (2) | %
Operating income | ​ | ​ | 134 | ​ | ​ | 125 | ​ | ​ | 9 | ​ | 7 | %

​

Net sales. Our decrease in net sales of 2 percent for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, was driven by a 6 percent reduction in volume, which was partially offset by a 3 percent increase in price mix and 1 percent increase in foreign exchange.

​

Operating income. Our operating income increased by $9 million for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020. The increase was driven by lower net corn costs and favorable price mix.

​

South America

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​ | Favorable (Unfavorable) | ​ | Favorable (Unfavorable) | ​
(in millions) |  | 2021 |  | 2020 |  | Variance |  | Percentage | ​
Net sales to unaffiliated customers | ​ | $ | 273 | ​ | $ | 237 | ​ | $ | 36 | ​ | 15 | %
Operating income | ​ | ​ | 40 | ​ | ​ | 26 | ​ | ​ | 14 | ​ | 54 | %

​

Net sales. Our net sales increased 15 percent for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, primarily due to an 20 percent increase in favorable price mix and 4 percent increase in volumes, partially offset by unfavorable foreign exchange impact of 9 percent.

​

Operating income. Our increase in operating income of $14 million for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, was primarily due to strong price mix and favorable net corn costs.

​

Asia-Pacific

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​ | Favorable (Unfavorable) | ​ | Favorable (Unfavorable) | ​
(in millions) |  | 2021 |  | 2020 |  | Variance |  | Percentage | ​
Net sales to unaffiliated customers | ​ | $ | 235 | ​ | $ | 189 | ​ | $ | 46 | ​ | 24 | %
Operating income | ​ | ​ | 25 | ​ | ​ | 20 | ​ | ​ | 5 | ​ | 25 | %

​

Net sales. Our net sales increased 24 percent for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020. 12 percent of the increase was due to the inclusion of PureCircle results in the 2021 period. In addition, there was a 6 percent increase in volumes and foreign exchange was 6 percent favorable.

​

28

Table of Contents

Operating income. Our operating income increased by $5 million for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020. The increase was driven by the recovery of South Korea and China from prior year pandemic impacts.

​

EMEA

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​ | Favorable (Unfavorable) | ​ | Favorable (Unfavorable) | ​
(in millions) |  | 2021 |  | 2020 |  | Variance |  | Percentage | ​
Net sales to unaffiliated customers | ​ | $ | 161 | ​ | $ | 154 | ​ | $ | 7 | ​ | 5 | %
Operating income | ​ | ​ | 31 | ​ | ​ | 27 | ​ | ​ | 4 | ​ | 15 | %

​

Net sales. Our net sales increased by 5 percent for the three months ended March 31, 2021, as compared to the three months ended March 31, 2020, primarily driven by favorable foreign exchange of 5 percent and favorable price mix of 3 percent. These items were partially offset by a 3 percent decrease in volume.

​

Operating income. Our operating income increased $4 million for the three months ended March 31, 2021, as compared to the March 31, 2020. The increase was largely attributable to favorable price mix and lower raw material costs in Pakistan.

​

Liquidity and Capital Resources

​

Cash provided by operating activities for the three months ended March 31, 2021 was $22 million, as compared to $65 million for the three months ended March 31, 2020. The decrease in operating cash flow was primarily driven by our changes in working capital. Cash used for investing activities for the three months ended March 31, 2021 was $64 million, as compared to $96 million for the three months ended March 31, 2020. The change was driven by the timing of capital expenditures and mechanical stores purchases, which totaled $63 million for the three months ended March 31, 2021, compared to $98 million for the three months ended March 31, 2020.

​

​

As of March 31, 2021, our total debt consists of the following:

​

​ | ​ | ​ | ​ | ​
(in millions) |  | ​ |
2.900% senior notes due June 1, 2030 |  | $ | 594 | ​
3.200% senior notes due October 1, 2026 | ​ | ​ | 497 | ​
3.900% senior notes due June 1, 2050 | ​ | ​ | 390 | ​
6.625% senior notes due April 15, 2037 | ​ | ​ | 253 | ​
Revolving credit facility | ​ | ​ | — | ​
Other long-term borrowings | ​ | ​ | 15 | ​
Total long-term debt | ​ | ​ | 1,749 | ​
Amended term loan credit agreement due March 15, 2022 | ​ | ​ | 380 | ​
Other short-term borrowings | ​ | ​ | 68 | ​
Total short-term borrowings | ​ | ​ | 448 | ​
Total debt | ​ | $ | 2,197 | ​

​

During the first quarter ended March 31, 2021, we amended and restated our term loan credit agreement (the “Amended Term Loan Credit Agreement”). The Amended Term Loan Credit Agreement restates the previous agreement by extending the maturity date of the borrowings under the previous agreement until March 15, 2022. No new borrowings under the Amended Term Loan Credit Agreement were incurred in connection with the amendment and restatement. Borrowings under the Amended Term Loan Credit Agreement bear interest at a variable annual rate based on London Interbank Offering Rate (“LIBOR”) or a base rate, at our election, subject to the terms and conditions thereof, plus, in each case, an applicable margin. The Amended Term Loan Credit Agreement reduces the applicable interest rate margin for loans accruing interest based on LIBOR from 0.80 percent to 0.75 percent. The Company is required to pay a fee on the unused availability under the Amended Term Loan Credit Agreement. The Amended Term Loan Credit Agreement contains customary representations, warranties, covenants and events of default, including covenants restricting the incurrence of liens, the incurrence of indebtedness by our subsidiaries and certain fundamental changes involving us and our subsidiaries, subject to certain exceptions in each case. We must also maintain a specified maximum consolidated leverage ratio and a specified minimum consolidated interest coverage ratio. As of March 31, 2021, we were in compliance

29

Table of Contents

with these financial covenants. The occurrence of an event of default under the Amended Term Loan Credit Agreement could result in all loans and other obligations being declared due and payable and the term loan credit facility being terminated.

​

As of March 31, 2021, in addition to approximately $1.0 billion of borrowing availability under our revolving credit facility, we have approximately $736 million of unused operating lines of credit in the various foreign countries in which we operate.

​

The weighted average interest rate on our total indebtedness was approximately 3.4 percent for the three months ended March 31, 2021, compared to 3.9 percent for the three months ended March 31, 2020.

​

On March 16, 2021, our Board of Directors declared a quarterly cash dividend of $0.64 per share of common stock. This dividend was paid on April 26, 2021, to stockholders of record at the close of business on April 1, 2021. Additionally, during the first quarter of 2021, we repurchased 158 thousand outstanding shares of common stock in open market transactions at a net cost of $14 million.

​

We have not provided foreign withholding taxes, state income taxes, and federal and state taxes or foreign currency gains/losses on accumulated undistributed earnings of certain foreign subsidiaries because these earnings are considered to be permanently reinvested. It is not practicable to determine the amount of the unrecognized deferred tax liability related to the undistributed earnings. We do not anticipate the need to repatriate funds to the U.S. to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service requirements. Approximately $444 million of the total $577 million of cash and cash equivalents and short-term investments at March 31, 2021 was held by our operations outside of the U.S.

​

We expect that available cash balances and borrowings expected to be available under the revolving credit facility, together with cash generated from operations and our access to debt markets, will be sufficient to meet our operating and other cash needs for at least the next twelve months.

​

Hedging and Financial Risk

​

Hedging: We are exposed to market risk stemming from changes in commodity prices (primarily corn and natural gas), foreign-currency exchange rates, and interest rates. In the normal course of business, we actively manage our exposure to these market risks by entering into various hedging transactions, authorized under established policies that place controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment grade counterparties. Our hedging transactions may include, but are not limited to, a variety of derivative financial instruments such as commodity-related futures, options and swap contracts, forward currency-related contracts and options, interest rate swap agreements, and Treasury lock agreements (“T-Locks”). See Note 6 of the Notes to the Condensed Consolidated Financial Statements included in this report for additional information.

​

Commodity Price Risk: Our principal use of derivative financial instruments is to manage commodity price risk in North America relating to anticipated purchases of corn and natural gas to be used in our manufacturing process. We periodically enter into futures, options and swap contracts for a portion of our anticipated corn and natural gas usage, generally over the following 12 to 24 months, in order to hedge price risk associated with fluctuations in market prices. Unrealized gains and losses associated with marking our commodities-based cash flow hedge derivative instruments to market are recorded as a component of other comprehensive loss (“OCL”). As of March 31, 2021, our Accumulated other comprehensive loss account (“AOCL”) included $67 million of net gains (net of income tax expense of $24 million) related to these derivative instruments. It is anticipated that $67 million of net gains (net of income tax expense of $24 million) will be reclassified into earnings during the next 12 months. We expect the net gains to be offset by changes in the underlying commodities costs.

​

30

Table of Contents

Foreign-Currency Exchange Risk: Due to our global operations, including operations in many emerging markets, we are exposed to fluctuations in foreign-currency exchange rates. As a result, we have exposure to translational foreign-exchange risk when our foreign operations’ results are translated to U.S. dollars and to transactional foreign-exchange risk when transactions not denominated in the functional currency of the operating unit are revalued into U.S. dollars. We primarily use derivative financial instruments such as foreign-currency forward contracts, swaps and options to manage our foreign currency transactional exchange risk. We enter into foreign-currency derivative instruments that are designated as both cash flow hedging instruments as well as instruments not designated as hedging instruments as defined by Accounting Standards Codification 815, Derivatives and Hedging. As of March 31, 2021, we had foreign currency derivatives not designated as hedging instruments hedging certain asset and liability positions with aggregate notional amounts of $487 million and $276 million, respectively.

​

As of March 31, 2021, we had foreign currency derivatives designated as cash flow hedging instruments hedging certain asset and liability positions with aggregate notional amounts of $256 million and $422 million, respectively. The amount included in AOCI relating to these hedges at March 31, 2021, was an insignificant amount of net losses (net of income tax benefit of $1 million). It is anticipated that $2 million of net losses (net of income tax benefit of $1 million) will be reclassified into earnings during the next 12 months.

​

Interest Rate Risk: We occasionally use interest rate swaps and T-Locks to hedge our exposure to interest rate changes, to reduce the volatility of our financing costs, or to achieve a desired proportion of fixed versus floating rate debt, based on current and projected market conditions. We did not have outstanding T-Locks as of March 31, 2021.

​

As of March 31, 2021, AOCL included $4 million of net losses (net of an income tax benefit of $1 million) related to previously settled T-Locks. Once T-Locks are settled, deferred losses are amortized to financing costs over the terms of the senior notes with which they are associated. It is anticipated that $1 million of net losses (net of an insignificant amount of taxes) will be reclassified into earnings during the next 12 months.

​

As of March 31, 2021, we did not have any interest rate swap agreements. As of March 31, 2020, we had an interest rate swap that effectively converted the interest rates on $200 million of our $400 million of 4.625% senior notes due November 1, 2020, to variable rates, which was paid in July 2020. This swap agreement called for us to receive interest at the fixed coupon rate of the notes and to pay interest at a variable rate based on the six-month U.S. dollar LIBOR plus a spread. As of March 31, 2020, we designated this interest rate swap agreement as a hedge of the changes in fair value of the underlying debt obligation attributable to changes in interest rates and accounted for it as a fair value hedge. The fair value of the interest rate swap agreement as of March 31, 2020 was a $4 million gain, and was reflected in the Condensed Consolidated Balance Sheets within Other assets, with an offsetting amount recorded in Long-term debt to adjust the carrying amount of the hedged debt obligations.

​

​

Critical Accounting Policies and Estimates

​

Our critical accounting policies and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no other changes to our critical accounting policies and estimates during the three months ended March 31, 2021.

​

31

Table of Contents

FORWARD-LOOKING STATEMENTS

​

This Form 10-Q contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends these forward-looking statements to be covered by the safe harbor provisions for such statements.

Forward-looking statements include, among others, any statements regarding the Company’s future prospects or financial condition, earnings, revenues, tax rates, capital expenditures, cash flows, expenses or other financial items, any statements concerning the Company’s prospects or future operations, including management’s plans or strategies and objectives therefor, and any assumptions, expectations or beliefs underlying the foregoing.

These statements can sometimes be identified by the use of forward-looking words such as “may,” “will,” “should,” “anticipate,” “assume,” “believe,” “plan,” “project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,” “outlook,” “propels,” “opportunities,” “potential,” “provisional,” or other similar expressions or the negative thereof. All statements other than statements of historical facts in this report or referred to in or incorporated by reference into this report are “forward-looking statements.”

These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and beyond our control. Although we believe our expectations reflected in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.

Actual results and developments may differ materially from the expectations expressed in or implied by these statements, based on various factors, including the impact of COVID-19 on the demand for our products and our financial results; changing consumption preferences relating to high fructose corn syrup and other products we make; the effects of global economic conditions and the general political, economic, business, and market conditions that affect customers and consumers in the various geographic regions and countries in which we buy our raw materials or manufacture or sell our products, including, particularly, economic, currency, and political conditions in South America and economic and political conditions in Europe, and the impact these factors may have on our sales volumes, the pricing of our products and our ability to collect our receivables from customers; future financial performance of major industries which we serve and from which we derive a significant portion of our sales, including, without limitation, the food, beverage, animal nutrition, and brewing industries; the uncertainty of acceptance of products developed through genetic modification and biotechnology; our ability to develop or acquire new products and services at rates or of qualities sufficient to gain market acceptance; increased competitive and/or customer pressure in the corn-refining industry and related industries, including with respect to the markets and prices for our primary products and our co-products, particularly corn oil; the availability of raw materials, including potato starch, tapioca, gum Arabic, and the specific varieties of corn upon which some of our products are based, and our ability to pass along potential increases in the cost of corn or other raw materials to customers; energy costs and availability, including energy issues in Pakistan; our ability to contain costs, achieve budgets, and realize expected synergies, including with respect to our ability to complete planned maintenance and investment projects on time and on budget and realize expected savings under our Cost Smart program as well as with respect to freight and shipping costs; the behavior of financial and capital markets, including with respect to foreign currency fluctuations, fluctuations in interest and exchange rates and market volatility and the associated risks of hedging against such fluctuations; our ability to successfully identify and complete acquisitions or strategic alliances on favorable terms as well as our ability to successfully integrate acquired businesses or implement and maintain strategic alliances and achieve anticipated synergies with respect to all of the foregoing; operating difficulties at our manufacturing facilities; the impact of impairment charges on our goodwill or long-lived assets; changes in our tax rates or exposure to additional income tax liability; our ability to maintain satisfactory labor relations; the impact on our business of natural disasters, war, or similar acts of hostility, threats or acts of terrorism, the outbreak or continuation of pandemics such as COVID-19, or the occurrence of other significant events beyond our control; changes in government policy, law, or regulation and costs of legal compliance, including compliance with environmental regulation; potential effects of climate change; security breaches with respect to information technology systems, processes, and sites; our ability to raise funds at reasonable rates and other factors affecting our access to sufficient funds for future growth and expansion; volatility in the stock market and other factors that could adversely affect our stock price; risks affecting the continuation of our dividend policy; and our ability to remediate in a timely manner a material weakness in our internal control over financial reporting.

32

Table of Contents

​

Our forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see “Risk Factors” and other information included in our Annual Report on Form 10-K for the year ended December 31, 2020 and in our subsequent reports on Forms 10-Q and 8-K.

​

ITEM 3

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

​

See the discussion set forth in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk at pages 55 to 56 in our Annual Report on Form 10-K for the year ended December 31, 2020 for a discussion of the manner in which we address risks with respect to interest rates, raw material and energy costs and foreign currencies. There have been no material changes in the information provided with respect to those disclosures during the first quarter of 2021. For additional information, also see “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Hedging and Financial Risk” in this report.

​

ITEM 4

CONTROLS AND PROCEDURES

​

Evaluation of Disclosure Controls and Procedures

​

Our management, including our Chief Executive Officer and our Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2021. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that as a result of the material weakness in our internal control over financial reporting described below, Ingredion’s disclosure controls and procedures were not effective as of March 31, 2021.

​

Changes in Internal Control Over Financial Reporting

​

During the three months ended March 31, 2021, our management continued updating certain internal controls and supporting processes to address the material weakness in our internal control over financial reporting described in our Annual Report on Form 10-K for the year ended December 31, 2020 related to ineffective information technology general controls (“ITGCs”) related to user access over certain information technology (“IT”) systems. These control deficiencies were the result of insufficient development of IT personnel as the control owners did not adequately understand the control objectives or the design of the control activity, as well as the result of ineffective timely communication of the control objective to these IT personnel by management. To date, management has provided enhanced control training for ITGC owners, and we have designed and are in process of implementing our improved documentation of the user access review that more clearly communicates the control objective and management’s documentation requirements. We expect remediation of this material weakness will be completed by the end of the third quarter of 2021.

​

We acquired PureCircle and Verdient in the third and fourth quarters of 2020, respectively, and are currently in the process of evaluating and integrating the acquired operations, processes and internal controls. See Note 3 of the Notes to the Condensed Consolidated Financial Statements included in this report for additional information regarding the acquisitions.

​

Other than as described above, there were no changes to our internal control over financial reporting that occurred during the three months ended March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

​

​

33

Table of Contents

​

PART II OTHER INFORMATION

​

ITEM 1

LEGAL PROCEEDINGS

​

In 2015 and 2016, the Company self-reported certain monitoring and recordkeeping issues relating to environmental regulatory matters involving its Indianapolis, Indiana manufacturing facility. In September 2017, following inspections and the provision by the Company of requested information to the U.S. Environmental Protection Agency (the “EPA"), the EPA issued the Company a Notice of Violation, which included additional alleged violations beyond those self-reported by the Company. These additional alleged violations primarily relate to the results of stack testing at the facility. The allegations in the Notice of Violation, whether from the self-reported information, the inspections or the additional requested information, are not material to us. The EPA has referred the overall matter to the U.S. Department of Justice, Environment and Natural Resources Division (the "DOJ"). The DOJ and the Company are engaged in discussions with respect to a resolution of this matter.

​

We are currently subject to claims and suits arising in the ordinary course of business, including those relating to labor matters, certain environmental proceedings, and commercial claims. We also routinely receive inquiries from regulators and other government authorities relating to various aspects of our business, including with respect to compliance with laws and regulations relating to the environment, and at any given time, we have matters at various stages of resolution with the applicable governmental authorities. The outcomes of these matters are not within our complete control and may not be known for prolonged periods of time. We do not believe that the results of currently known legal proceedings and inquires will be material to us. There can be no assurance, however, that such claims, suits or investigations or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on our financial condition or results of operations.

​

​

​

ITEM 2

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

​

Issuer Purchases of Equity Securities:

​

The following table presents information regarding our repurchase of shares of our common stock during the three months ended March 31, 2021.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Maximum Number |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (or Approximate |
​ | ​ | ​ | ​ | ​ | ​ | Total Number of | ​ | Dollar Value) of |
​ | ​ | Total | ​ | Average | ​ | Shares Purchased as | ​ | Shares That May Yet |
​ | ​ | Number | ​ | Price | ​ | Part of Publicly | ​ | be Purchased Under |
​ | ​ | of Shares | ​ | Paid | ​ | Announced Plans or | ​ | the Plans or Programs |
(shares in thousands) | ​ | Purchased | ​ | per Share | ​ | Programs | ​ | at End of Period | ​
January 1 – January 31, 2021 |  | — |  | — |  | — |  | 5,855 shares | ​
February 1 – February 28, 2021 |  | — |  | — |  | — |  | 5,855 shares | ​
March 1 – March 31, 2021 | ​ | 158,065 |  | 89.59 |  | 158,065 | ​ | 5,697 shares | ​
Total |  | 158,065 |  | 89.59 |  | 158,065 | ​ | ​ | ​

​

On October 22, 2018, the Board of Directors authorized a stock repurchase program permitting us to purchase up to an additional 8.0 million shares of our outstanding common stock from November 5, 2018, through December 31, 2023. As of March 31, 2021, we have 5.7 million shares available for repurchase under the stock repurchase program.

​

​

34

Table of Contents

ITEM 6

EXHIBITS

​

a) Exhibits

​

Exhibits required by Item 601 of Regulation S-K are listed in the Exhibit Index below.

​

EXHIBIT INDEX

​

| ​ |
Number | ​ | Description of Exhibit
​ | ​ | ​
10.1 | ​ | Second Amended and Restated Term Loan Credit Agreement, dated as of March 16, 2021, among Ingredion Incorporated, as Borrower, the Lenders party thereto and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K dated March 18, 2021, filed on March 18, 2021 (File No. 1-13397)).
​ | ​ | ​
10.2*† | ​ | Form of Performance Share Award Agreement for use in connection with awards under the Stock Incentive Plan.
​ | ​ | ​
10.3*† | ​ | Form of Restricted Stock Units Award Agreement for use in connection with awards under the Stock Incentive Plan.
​ | ​ | ​
31.1† | ​ | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
31.2† | ​ | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
32.1†† | ​ | Certification of Chief Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
​ | ​ | ​
32.2†† | ​ | Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.
​ | ​ | ​
101.INS† ​ | ​ | XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
​ | ​ | ​
101.SCH† ​ | ​ | Inline XBRL Taxonomy Extension Schema Document. ​
101.CAL† ​ | ​ | Inline XBRL Taxonomy Extension Calculation Linkbase Document. ​
101.DEF† ​ | ​ | Inline XBRL Taxonomy Extension Definition Linkbase Document. ​
101.LAB† ​ | ​ | Inline XBRL Taxonomy Extension Label Linkbase Document. ​
101.PRE† ​ | ​ | Inline XBRL Taxonomy Extension Presentation Linkbase Document. ​
104† | ​ | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document, which is contained in Exhibit 101).

_____________________________________

​ ​ HIDDEN_ROW | ​ | ​ ​
† ​ | ​ | Filed with this report.
†† ​ | ​ | Furnished with this report.

35

Table of Contents

* | ​ | Management contract or compensatory plan or arrangement to be filed as an exhibit to this form pursuant to Item 6 of this report.

​

​

​

36

Table of Contents

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​

​

​ | ​ | INGREDION INCORPORATED
​ | ​ | ​
​ | ​ | ​
DATE: | May 7, 2021 | By | /s/ James D. Gray
​ | ​ | James D. Gray
​ | ​ | Executive Vice President and Chief Financial Officer
​ | ​ | ​
​ | ​ | ​
​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | ​

​

​

​

​

​

​

​

​

37